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ABSTRACT
The accuracy of electron dose calculations performed by two commercially 
available treatment planning computers, Varian Cadplan and Helax TMS, has been 
assessed. Measured values of absorbed dose delivered by a Varian 2100C linear 
accelerator, under a wide variety of irradiation conditions, were compared with 
doses calculated by the treatment planning computers.
Much of the motivation for this work was provided by a requirement to verify the 
accuracy of calculated electron dose distributions in situations encountered 
clinically at Glasgow’s Beatson Oncology Centre. Calculated dose distributions 
are required in a significant minority of electron treatments, usually in cases 
involving treatment to the head and neck. Here, therapeutic electron beams are 
subject to factors which may cause non-uniformity in the distribution of dose, and 
which may complicate the calculation of dose. The beam shape is often irregular, 
the beam may enter the patient at an oblique angle or at an extended source to skin 
distance (SSD), tissue inhomogeneities can alter the dose distribution, and tissue 
equivalent material (such as wax) may be added to reduce dose to critical organs.
Technological advances have allowed the current generation of treatment planning 
computers to implement dose calculation algorithms with the ability to model 
electron beams in these complex situations. These calculations have, however, yet 
to be verified by measurement.
This work has assessed the accuracy of calculations in a number of specific 
instances. Chapter two contains a comparison of measured and calculated planar 
electron isodose distributions. Three situations were considered: oblique 
incidence, incidence on an irregular surface (such as that which would be arise 
from the use of wax to reduce dose to spinal cord), and incidence on a phantom 
containing a small air cavity. Calculations were compared with measurements 
made by thermoluminescent dosimetry (TLD) in a WTe electron solid water 
phantom.
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Chapter three assesses the planning computers’ ability to model electron beam 
penumbra at extended SSD. Calculations were compared with diode 
measurements in a water phantom. Further measurements assessed doses in the 
junction region produced by abutting an extended SSD electron field with opposed 
photon fields.
Chapter four describes an investigation of the size and shape of the region enclosed 
by the 90% isodose line when produced by limiting the electron beam with square 
and elliptical apertures. The 90% isodose line was chosen because clinical 
treatments are often prescribed such that a given volume receives at least 90% 
dose. Calculated and measured dose distributions were compared in a plane 
normal to the beam central axis. Measurements were made by film dosimetry.
While chapters two to four examine relative doses, chapter five assesses the 
accuracy of absolute dose (or output) calculations performed by the planning 
computers. Output variation with SSD and field size was examined. Two further 
situations already assessed for the distribution of relative dose were also 
considered: an obliquely incident field, and a field incident on an irregular surface.
The accuracy of calculations was assessed against criteria stipulated by the 
International Commission on Radiation Units and Measurement (ICRU). These 
set upper limits on the error in calculated dose of 2% (or 2 mm in the position of a 
given dose).
Using these criteria, the 2D dose distributions examined in chapter two were 
calculated with acceptable accuracy in most situations. The most notable 
exception was a 10% overestimation in dose made by both planning computers for 
points downstream of the small air cavity. This was caused by the assumption of 
an infinite lateral extent to the air cavity made while assessing dose to points 
immediately beneath the cavity.
The calculated position of the 90% isodose line in relation to field defining 
apertures (considered in chapter three) proved accurate in all circumstances. As a
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result, it has been proposed that the TMS planning system produce a library of 
dose distributions relating to the set of standard elliptical apertures used in breast 
boost radiotherapy at the Beatson Oncology Centre.
Beam penumbra at extended SSD was modelled accurately by the planning 
computers at SSD values up to and including 110 cm. At higher SSDs, the 
position of the centre of the penumbra was modelled successfully, but 
unacceptable errors in the penumbra width occurred. Adjacent photon and 
electron fields were found to produce minimum dose inhomogeneity in the 
junction region if fields were positioned with a gap between the geometric field 
edges (as defined by the light field). The gap varied within a range of 1 -  4 mm, 
dependent on electron energy and SSD.
The calculation of absolute dose, assessed in chapter five, achieved less accuracy 
than the relative dose calculations considered previously. Errors in excess of 2% 
in the calculations of both planning systems were often found for extended SSD 
fields. At the standard SSD, TMS produced large errors (up to 8%) in output for 
field sizes less than 5 cm square. The assessment revealed fundamental flaws in 
the algorithms employed by both planning systems in the calculation of monitor 
units. Neither manufacturer has made a commitment to remedy these problems in 
the immediate future.
In conclusion, the Varian Cadplan and Helax TMS treatment planning systems 
produce acceptable accuracy in the calculation of relative dose from therapeutic 
electron beams in most commonly encountered situations. When interpreting 
clinical dose distributions, however, knowledge of the limitations of the calculation 
algorithm employed by each system is required in order to identify the minority of 
situations where results are not accurate. The calculation of absolute dose is too 
inaccurate to implement in a clinical environment.
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CHAPTER 1 
INTRODUCTION
1.1 The clinical use of electron beams
The benefits of high energy electrons for the treatment of cancer were first reported 
in 1952 [1]. In the following decades, electron therapy established itself as a 
valuable alternative treatment modality to the more common X-ray therapy. By 
1990, the clinical benefits of electron treatments had been noted for a diverse range 
of treatment sites including nodal disease of the neck; skin carcinomas; the salivary 
gland; and low pelvic tumours [2-4]. The value of post-operative electron 
radiotherapy to the resection margins of the breast following lumpectomy was 
recognised internationally [5,6]. Treatments to the head and neck, breast and skin 
form the majority of electron treatments carried out in current clinical practice.
To be suitable for electron therapy, a treatment volume must be confined to within 
a few centimetres of the skin surface. If this condition is met, the characteristic 
electron depth dose profile, involving a region of uniform high dose at shallow 
depths followed by a rapid decline in dose, results in full dose delivery to the 
target, while sparing the underlying normal tissues. This is a crucial advantage, 
and is the main reason for persisting with electron therapy; in other respects 
electrons have many disadvantages. Most of these are related to the ease with 
which electrons scatter away from dense objects, and scatter into less dense 
objects. This can result in a very non-uniform distribution of absorbed dose, and 
makes the interaction of electrons with inhomogeneous absorbers (such as a 
patient) difficult to model theoretically.
The majority of electron treatments are given as a single field with normal 
incidence. The simplicity of this set-up, together with the difficulties in modelling 
electron behaviour, meant early electron treatments were prescribed with reference 
to a single central axis depth dose. Computer assisted calculations of dose 
distribution were seen as unnecessary and even undesirable. However, as the use 
of computers in treatment planning became widespread in the late 1960s and the
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1970s, this situation began to change. As early as 1967 [7], it was recognised that, 
in treatments of the head and neck, for example, irregularities in the patient 
surface, or the presence of tissue inhomogeneities like the trachea, could result in 
non-uniform dose distributions, or the displacement of the high dose region to 
greater or lesser depth. Failure to account for these effects, by adopting too 
simplistic a planning approach, could have damaging consequences for treatments 
delivered in close proximity to critical structures such as spinal cord.
1.2 Theoretical models of clinical electron beams
In both the United States and Europe, efforts were made to address the 
inaccuracies in electron dose calculations by implementing computer algorithms 
based on the interpolation of measured data [7,8]. No attempt was made to model 
electron scatter in the patient explicitly; regions of high or low density were 
handled by applying an equivalent path length correction to dose in a “line of 
sight” downstream of the inhomogeneity. While this simplification was capable 
of producing treatment plans giving a general impression of dose distribution, 
accuracy could not be assured in situations involving irregular beam entry surfaces, 
oblique incidence, or tissue inhomogeneities.
To improve the accuracy of calculated electron dose distributions, it was realised 
that the basic transport processes undergone by electrons in a scattering medium 
would have to be considered explicitly. Two alternative descriptions of the 
transport processes have been developed. The first, due to Bethe et al [9], relies 
on a diffusion approximation of electron behaviour, while a later theory developed 
by Eyges [10] examines multiple scattering events. The importance of scattering 
theory in the modelling of clinical electron beams is discussed further in chapter 
two.
1.3 Pencil beam algorithms
By the 1980s, attempts to implement scattering theory in a practical way for 
clinical electron beams led to the development of the pencil beam algorithm [11].
In this system, the electron beam is modelled as a series of infinitesimally small 
beams which enter the patient in a grid pattern and spread out with depth in the 
absorber. This approach was similar to many already adopted for photon beam 
algorithms. The pattern of electron scatter away from a central axis predicted by 
both the diffusion and multiple scattering models was represented by a Gaussian 
function. The mathematical formalism behind the Gaussian spread technique for 
electron pencil beams was developed independently by Hogstrom et al in the 
United States [12], and by Brahme and his co-workers in Sweden [13.] Early 
implementations of the algorithm gave encouraging results in the modelling of 
clinical beams incident on irregular surfaces and inhomogeneous phantoms [14]. 
The pencil beam model subsequently gained widespread acceptance.
Pencil beam algorithms have undergone a series of refinements since their 
introduction. An important improvement was the replacement of the single 
Gaussian (or Hogstrom) model of radial spread with the summation of three 
Gaussian functions [15]. This latter approach makes a better assessment of the 
contribution to the spread of pencil beams made by secondary electrons, which are 
not included in the scattering theory of Eyges. It also contains a reduction factor 
to account for range straggling, a quantum mechanical phenomenon resulting in a 
reduced path length for electrons undergoing large angle scattering events. Both 
treatment planning systems considered in this work, Varian Cadplan and Helax 
TMS, use pencil beams based on the three Gaussian beam approach. There are 
differences, however, in the way each planning system implements the algorithm 
in the calculation of relative absorbed dose. These are discussed in chapter two.
1.4 Published assessments of pencil beam algorithms
There has been considerable effort made towards assessing the accuracy of modern 
pencil beam calculation algorithms. The majority of published work is directed 
towards photon calculations, but there has also been interest in assessing electron 
calculations. Evaluations of planning systems based on the Hogstrom algorithm 
have been reported by McShan et al [16], Cheng et a/ [17] and by Muller-Runkel 
and Sang-Hyun [18].
The only published assessment of the Helax TMS system is that due to Blomquist 
et al [19], who examined software version 2.10J in the calculation of relative 
electron dose for a variety of phantom geometries. Monitor unit calculations were 
not considered. In general, the TMS calculations were found to be within +/- 2% 
of measured values, and an improvement over those reported as resulting from the 
Hogstrom algorithm. Greater inaccuracies were reported in a number of specific 
instances. These included oblique incidence of the beam, where a 7 mm 
discrepancy in penumbra position was reported, and incidence on a phantom 
containing a small air space.
Published reports on the accuracy of the Cadplan algorithm are limited to the work 
of Samuel son et al [20]. This work reported on the accuracy of relative dose and 
monitor unit calculations produced by Cadplan version 2.62. As with TMS, the 
calculations were generally accurate to within +/- 2% in most situations.
Exceptions to this were, however, reported in situations involving the modelling of 
small air cavities, and for relative off-axis doses in large fields. Here, errors of up 
to 7% were attributed to limitations in the modelling of the electron scattering foil.
1.5 Assessments performed in this work
The test results presented in later chapters of this current work complement 
existing publications, and have the additional benefit of providing a direct 
comparison of the performance of the TMS and Cadplan calculation algorithms. 
The scarcity of published assessments of monitor unit calculations (particularly for 
TMS) is addressed in chapter five, which is devoted to this topic. Much of the 
motivation for some specific tests originated from an acute need for the evaluation 
of dose distributions resulting from clinical treatments performed at Glasgow’s 
Beatson Oncology Centre (B.O.C.). This was particularly true of the evaluation of 
breast boost cutouts reported in chapter four. Here, the aim was to provide 
clinicians with information on the nature of the field penumbra near the edge of 
commonly used field defining devices. The investigation of electron / photon 
junctions in chapter three, and the experiments assessing the planning computers’
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ability to predict relative dose in the vicinity of a bolus edge (described in chapter 
two) were also of immediate clinical relevance. The use of bolus to reduce dose to 
spinal cord, and the matching of electron and photon fields (ultimately for the same 
reason) are common in treatments of the head and neck in the B.O.C.
Chapter four, unlike the other chapters, considers only the TMS planning system. 
This is because, when this work was carried out, the facility for electron planning 
had yet to be commissioned on Cadplan. There would be limited benefit in 
extending the assessment to include Cadplan because the specific aim was to 
provide clinicians at the B.O.C, with information on the use of specially shaped 
field-defining cut-outs used in breast boost treatments. This was achieved 
satisfactorily with the aid of measurements made with radiographic film and 
calculations performed on the TMS system.
During the course of experimental work, both planning systems underwent a 
process of continuous development. Helax TMS graduated from version 2.9E to 
version 4.1 A while Varian Cadplan developed from version 2.7.9 to version 3.1.1. 
These changes reflected improvements to the photon calculation algorithms and 
user interfaces only. The particular software version under examination is given 
for both systems in each chapter. Neither planning system underwent any 
significant changes to the electron dose calculation algorithm, nor have any 
changes been made since the work presented here was completed [21,22]. All 
comparisons of measured and calculated data can, therefore, be considered 
applicable to the current software versions. At the time of writing, these were 
TMS v5.0A and Cadplan v6.0.8.
A valid judgement on the success of calculations made by treatment planning 
computers requires the definition of acceptance criteria for their accuracy. The 
International Commission on Radiation Units and Measurements (ICRU) 
stipulated appropriate criteria in report number 42 (on the use of computers in 
radiotherapy) [23]. On the subject of quality assurance, the report states that a 
computed dose distribution may be considered accurate “if it differs from relative 
dose measurements by less than 2% (or 2 mm in the position of isodose lines in
special circumstances involving very steep dose gradients) in points of relevance to 
the treatment”. These criteria have been used to assess the accuracy of dose 
calculation for the majority of this work. If other criteria are appropriate, these are 
justified in the context of the specific situation being examined.
CHAPTER 2 
PLANAR ISODOSE DISTRIBUTIONS IN A SOLID WATER PHANTOM
2.1 Introduction
2.1.1 Electron transport in tissue-equivalent materials.
In many clinical situations therapeutic electron beams are used in combination with 
beam modifiers such as bolus, or encounter non-standard patient geometries 
including oblique incidence and/or the presence of air cavities. Accurate 
prediction of the dose distribution in these situations requires detailed modelling of 
electron transport processes, both within the patient and in any overlaying bolus 
material. The theory underlying electron transport in solids was first described by 
Eyges and is known as the Fermi-Eyges small angle scattering theory [10]. In 
this theory, primary electrons are assumed to undergo two types of interaction with 
charged particles in the absorber. Firstly, inelastic collisions with atomic 
electrons; and secondly, elastic long range collisions with nuclei. It is assumed 
that these collisions result in only small angle deflections to the path of the primary 
electrons.
Eyges expressed the lateral displacement G(x,z) of a small electron beam as follows:
G{x, z) = —r =  exp 
■\J'27r(Jx{z) y '2.7ÏCT x{z) j
2.1
Where a(x,z) is a lateral spatial spread parameter dependent on the depth z and 
lateral displacement x in the absorber. In this context, a “small electron beam” is 
one whose initial diameter is small in comparison with the range of primary 
electrons in the absorber. The spread parameter determines the characteristic 
features of the electrons’ lateral spread. It was given by the expression
Where ^ /p l  is the mass angular scattering power and p  is the physical density of 
the absorber.
Modern computer systems are capable of providing numerical solutions to the 
theory for clinical electron beams via Monte Carlo simulations [24-26]. The 
calculations, however, remain too time-consuming to be implemented in day-to- 
day clinical practice.
2.1.2 Current scatter algorithms
In the early 1980s considerable effort was made to apply scattering theory to the 
modelling of clinical beams in a practicable way. The first models to be 
introduced were based on pencil beam algorithms developed independently by 
Hogstrom et a/ [12] and Brahme et al[\3'\. Later, another algorithm was reported 
by Wemer et al [27]. The term “pencil beam” refers to a mono-directional 
electron beam with a “small” diameter as defined above. After intersecting a 
patient or phantom surface, the beam spreads out with depth as electrons are 
scattered. The resulting distribution of energy deposition resembles the tip of an 
upturned pencil. Pencil beams originating from all parts of the phantom 
contribute to the dose at a given point at depth. These contributions are summed 
to yield the final dose.
The accuracy of pencil beam calculations depends crucially on the algorithm 
employed to model the spread of the pencil beam with depth. In order to save 
calculation time, electron scatter has not yet been modelled explicitly. Equations
2.1 and 2.2 are not implemented directly, but an approximation is used which, in 
the case of the Hogstrom algorithm, models the spread of electrons with a radially 
symmetric Gaussian function i.e. proportional to exp(-^/b^. This concept was 
developed further by Lax et a/ [15] who replaced the single Gaussian beam model 
with a summation of three Gaussians. This implementation makes a better 
assessment of the contributions made to the spread of pencil beams by large angle 
scattering and range straggling. Parameters for the Gaussian beams are derived 
from pre-calculated Monte Carlo kernels in homogeneous media and then scaled
for layered inhomogeneous media by the method described by Lax and Brahme 
[28]. It is this latter model on which both the TMS and Cadplan treatment 
planning systems base their electron dose calculations. The TMS algorithm was, 
however, supplied with updated Gaussian parameters following the work of 
Andreo and Ahnesjo in 1991 [29].
2.2 Materials and Methods
2.2.1 Thermoluminescent dosimeters
Dose calculations from the Helax TMS 4.1 A and Varian Cadplan 2.7.9 planning 
computers were compared with measurements made by thermoluminescence 
dosimetry in a solid water phantom. The phantom is described below. 
Thermoluminescent dosimeters (TLDs) were of the square chip variety with a flat 
surface area of width and length 3.0 mm and depth 0.9 mm (QADOS Ltd, Unit 9 
Compton Place, Surrey Avenue, Camberely, Surrey GUI 5 3DX). They were 
made from a proprietary material, LiFlOO, which consists of lithium fluoride 
doped with a variety of impurities. Among the impurities, divalent positive ions 
residing in the interstitial lattice spaces are thought to play an important role in 
enhancing the thermoluminescence process [30]. Electrons ejected from the 
lattice by ionising radiation are trapped in metastable excited energy states 
provided by the impurities and, following promotion to a higher energy level by 
thermal lattice vibrations, drop to the ground state with the emission of photons in 
the visible spectrum. This final emission is proportional to the original ionising 
radiation incident on the material.
The suitability of lithium fluoride for reproducible and accurate
thermo luminescence dosimetry has been previously noted by the ICRU [31].
TLDs have a large response per unit volume, enabling the use of small sizes for 
measurement. Since there are often steep absorbed dose gradients in clinical 
electron beams, the small size makes TLDs very useful. Prior to their use in the 
comparison experiments, the TLDs were assessed for sensitivity, and an individual 
calibration factor assigned to each. This process is described in detail in appendix
A2.1. The mean standard deviation in sensitivity for a series of measurements 
made with any individual TLD was calculated as 1.0%.
Mayles et al [32] conclude that the percentage standard error in any individual 
measurement of thermoluminescence can be found by the addition, in quadrature, 
of this standard deviation with a factor related to the number of repetitions made in 
the initial calibration measurements. As shown in appendix A2.1, the result of 
this addition is a standard error in thermoluminescence of +/- 1.1% for a single 
measurement. Estimates of relative absorbed dose result from taking the ratio of 
two thermoluminescence measurements; one at the location in question, the other 
at the normalisation point. The total standard error in relative absorbed dose may 
thus be estimated by adding the standard errors in each of these two measurements 
in quadrature. This gives a total uncertainty in measurements of relative absorbed 
dose of 2%. This is at the lower end of commonly quoted values for individually 
calibrated chips of LiFlOO, but is not without precedent in the literature [33].
2.2.2 The phantom
TLDs were situated in precisely milled cut-outs made in a slab of WTe solid water, 
an epoxy resin based water substitute (St Bartholomews Hospital, 2"  ^floor 80 
Bartholomew Close, West Smithfield, London ECl A 7BE). Measurements were 
made in a phantom which consisted of separate sections of WTe, each with a 
square cross-section of 25 cm x 25 cm. Sections of various thickness were 
available which allowed the slab accommodating the TLDs to be placed at various 
depths. The thickness of each solid water section was measured with a 
micrometer and found to be within +/- 0.1 mm of the nominal thickness. By first 
measuring its weight with an electronic balance, the density of WTe was 
determined as 1.027 +/- 0.005 gcm'^. In accordance with IPEMB 
recommendations [34], a minimum of 10 cm backscatter material was employed 
throughout. Exposures were made with a Clinac 21OOC linear accelerator (Varian 
Associates, Palo Alto, California, USA) at electron beam energies in the range 6 to 
20 MeV.
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Nisbet and Thwaites [35] reported that depth ionisation curves measured in WTe 
and in water are in agreement to within +/- 0 .5 mm for electron beams with 
incident energies in the range 5 to 17 MeV. Furthermore, the equivalence of depth 
ionisation measured with a p-type diode detector in water, and depth dose in water, 
has been noted by the ICRU [31], A comparison showing the equivalence of 
depth ionisation in water to depth thermoluminescence in WTe would, therefore, 
confirm the equivalence of depth thermoluminescence in WTe to depth dose in 
water. To confirm this, central axis depth ionisation curves were obtained with a 
diode detector in a water phantom and compared to relative thermoluminescence 
readings obtained with TLDs at corresponding depths in WTe. Beam energies of 
6, 12 and 16 MeV were considered at a field size of 10 cm x 10 cm and SSD of 
100 cm. The diode detector used was a p-type device manufactured by 
Scanditronix (QADOS Ltd, address as above). The device was interfaced to a 
Therados DPD5 electrometer (Therados Instrument AB, Dalgatan 15, Uppsala, 
Sweden).
2.2.3 Clinical Beam Experiments
A series of five experiments comparing measured with calculated dose 
distributions were now performed. Table 2.1 contains a description of each 
experiment, whilst figure 2.1 shows the cross-sections of each phantom. The first 
experiment examined the planning computers’ ability to predict central axis depth 
dose. Succeeding experiments were designed to test the ability of the planning 
computers to predict planar dose distributions resulting from beam set-ups 
encountered clinically. These are described below. Where possible, a beam 
energy of 12 MeV was employed since this is the most commonly encountered 
energy in treatments of the head and neck.
Oblique incidence: this is often inevitable in electron treatments of the head and 
neck. The experiment examined a 30° beam incident on a plane phantom. A SSD 
of 102 cm, rather than the standard treatment SSD of 100 cm, was required to 
prevent the treatment applicator colliding with the phantom.
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Bolus Edges: the addition of wax bolus over a portion of the treatment area is 
commonly used to limit dose to underlying structures such as spinal cord. A 
typical bolus depth of 2.0 cm was used. To illustrate the importance of the bolus 
geometry, both squared-off (90°) and smoothed (45°) edges were considered. 
Polymethylmethacrylate (PMMA) was used as the bolus material to provide a 
more precise and reproducible shape than that possible with wax (which is used 
clinically). The geometry was two-dimensional i.e. the bolus extended beyond the 
field edges in the direction normal to the measurement plane. The beam was 
incident normally on the phantom.
Trachea: irradiation of the neck is occasionally given at a sufficiently anterior 
angle of incidence, or with sufficiently energetic electrons, that the presence of the 
trachea cannot be ignored when assessing the resulting dose distribution. To 
simulate the trachea, a 1.5 cm diameter hollow cylinder was machined along the 
length of a solid water section at a depth (to the cylinder centre) of 4.0 cm. This 
experimental geometry was, therefore, also two-dimensional. A beam energy of 
20 MeV was used so that the air space fell within the high dose region of the depth 
dose curve. This situation ensures that perturbations in dose caused by the air 
space will not be swamped by the steep dose gradient of the fall-off region. The 
beam is incident normally on the phantom.
Experiment SSD
(cm)
Energy
(MeV)
Field Size 
(cm)
Measurement dimension 
X Y Z
Measurement
Technique
1. Central axis 
depth dose.
100 6,12,16 1 0 x 1 0 0 0 Var Diode
2. Oblique 
incidence.
102 12 1 0 x 1 0 Var 0 Var TLD
3. 90° Bolus edge. 100 12 1 9 x 1 9 Var 0 Var TLD
4. 45° bolus edge. 100 12 1 9 x 1 9 Var 0 Var TLD
5. Trachea. 100 20 15 x 1 5 Var 0 Var TLD
Table 2.1. Summary o f experiments performed to compare TLD measurements with planning 
computer calculations. Var indicates that the measurements were carried out at various points. X 
and Y refer to the photon collimator X and V axis directions. The Z dimension runs parallel to the 
beam central axis and so indicates depth below the phantom surface.
12
30 °
( 1).
2. G cm
2.0 cm
(3).
1.5 cmAir
(4). (5).
PMMA ^  WTe Solid Water
Figure 2.1. Phantom cross-sections used for experiments listed in table 2.1. Single arrows 
represent the electron beam central axis. (1) Normal incidence. (2) Oblique incidence o f 30°. 
(3) 90° bolus edge. (4) 45° bolus edge. (5) Cylindrical air cavity o f 1.5cm diameter.
2.4 Results
Figures 2.2 -  2.4 show depth ionisation curves measured with a diode in a water 
phantom together with the corresponding depth thermo luminescence curves 
recorded with TLDs in solid water. Curves are individually normalised to the 
depth of maximum dose (Dmax)- As discussed above, the ICRU have established 
that depth ionisation in water measured by a p-type diode detector is equivalent to 
relative absorbed dose over the range of electron beam energies considered in this 
work. The depth ionisation curves shown in figures 2-4 may thus be regarded as a 
description of the variation of absorbed dose with depth in water.
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Central axis depth dose. Diode measurements of central axis depth dose are 
compared with calculated values from the planning computers in figures 2 .5-2.7. 
Curves are individually normalised to Dmax-
Clinical beam experiments. Measured and calculated two-dimensional dose 
distributions resulting from an obliquely incident beam and beams incident on 
phantoms containing bolus and air spaces are shown in figures 2 .8 -2 .15 . TLD 
measurements were made at a series of discrete points forming a two-dimensional 
grid in the X-Z plane. This data was processed using a software algorithm 
developed specifically for the purpose using the Visual Basic programming 
language running under Microsoft Excel 97. On execution of the program, the 
discrete measurements are transformed to the equivalent isodose distribution. The 
algorithm used is presented as a flow diagram in appendix A2.2. Output from the 
program allows measured data to be compared directly with isodose distributions 
produced by the planning computers. In all cases, dotted lines represent measured 
data whilst solid lines represent calculated data. Lateral position “0” represents 
the beam central axis entry point in the collimator x direction.
The diode measurements shown in figures 2.2 -  2.4 show that the Dmax depth for 
12 MeV electrons is approximately 2.7 cm and that for 20 MeV electrons is 
approximately 1.7 cm. Consequently, the normalisation point for the obliquely 
incident field was set at an oblique depth of 2.7 cm along the beam central axis, 
and at a vertical depth of 1.7 cm for the trachea experiment. In both cases the 
measured and calculated data have the same normalisation point. For the bolus 
edge experiments, the Dmax depth on the central axis lies in a region of rapidly 
changing dose, making it unsuitable as a normalisation point. Dose distributions 
were, therefore, normalised at a distance of approximately 7 cm from the beam 
central axis and depth equal to the Dmax depth. The bolus edge phantoms 
produced scatter effects which lead to doses in excess of 1 2 0 %, localised in small 
areas. For clarity, the maximum isodose displayed is 110%. The values of hot 
spots are shown separately in figure 2.16.
14
6 M ev
100  
90  
80  
70  
60  
50  
40  
30  
20  
1 0 
0
X
—
->W
A A TLD  
X D i o d e
X
XA X-X-
1 0 2 0  3 0
D e p t h  ( m m )
4 0
Figure 2.2. Relative depth ionisation in water (measured by diode), 
and depth thermoluminescence in WTe solid water for a 6 MeV electron beam.
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Figure 2.3. Relative depth ionisation in water (measured by diode), 
and depth thermoluminescence in WTe solid water for a 12 MeV electron beam.
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Figure 2.4. Relative depth ionisation in water (measured by diode),and depth thermoluminescence 
in WTe solid water for a 16 MeV electron beam.
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Figure 2.5. Comparison o f measured and calculated %Central Axis Depth Dose (%CADD) for a 6 MeV, 
10x10 field. Measurements made with a diode in water, calculations from Helax TMS and Varian Cadplan.
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Figure 2.6 . Comparison o f measured and calculated %Central Axis Depth Dose (%CADD) for a 12 MeV, 
10x10 field. Measurements made with a diode in water, calculations from Helax TMS and Varian Cadplan.
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Figure 2.7. Comparison o f measured and calculated %Central Axis Depth Dose (%CADD) for a 16 MeV, 
10x10 field. Measurements made with a diode in water, calculations from Helax TMS and Varian Cadplan
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Figure 2.16. Comparison of measured and calculated doses for the hot spot behind a 45° tapered 
bolus edge and a 90°square bolus edge, for a 12MeV electron beam. Measurements made by TLD 
in WTe solid water, calculations by planning computers.
2.5 Discussion
The objective of this work was to assess the ability of two treatment planning 
systems, Helax TMS 4.1 A and Varian Cadplan 2.7.9, to calculate electron depth 
dose distributions accurately. In an attempt to reproduce the variety of conditions 
encountered clinically, both simple and complex phantoms have been used in a 
comparison of measured and calculated relative depth dose. The clinical 
situations considered were: oblique incidence; incidence near a bolus edge, and 
incidence on an area overlaying the trachea. Measurements were made with a 
diode in a water phantom and by thermoluminescence dosimetry in a WTe solid 
water phantom.
2.5.1 Measurement uncertainties
There are no formal protocols describing the use of TLDs in the measurement of 
electron depth dose. Before any conclusions can be drawn from its use, it is 
therefore, important to compare relative absorbed dose measured in this way with a 
method traceable to national standards. Currently, the national standard directs
that depth ionisation measured with a designated ion chamber in a water phantom
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is converted to absorbed dose by applying a series of environmental and chamber- 
related correction factors and an air kerma calibration [34]. As was noted in the 
results section, the ICRU have noted that depth ionisation measurements made 
with a diode in a water phantom can be regarded as being indicative of relative 
absorbed depth dose without the need for correction [31]. Diode measurements 
are thus indirectly traceable to national dosimetric standards. For simplicity 
therefore, the accuracy of TLD measurements was assessed by comparison with 
relative depth ionisation measured by a diode in a water phantom.
Both diode and TLD measurements were subject to some uncertainty in precision 
and accuracy. The diode could be positioned with an estimated uncertainty of +/- 
0.25 mm. The precision in measuring the position at which a certain dose occurs 
was thus no better than +/- 0.25 mm. In regions of high dose gradient the 
precision with which doses can be measured with a diode also depends on the 
accuracy of measurement (this will be discussed in chapter 3). This depends 
crucially on the size of the active volume over which the changing dose is 
averaged. Taking these factors into account, the overall uncertainty in the position 
at which a given dose occurs is likely to be +/- 1 . 0  mm for diode measurements.
The position of TLD dosimeters in the solid water phantom could be estimated 
with an uncertainty of approximately +/- 0.25 mm.
Measurements with TLDs were, in addition, subject to several factors which limit 
the accuracy of the recorded dose. As discussed in Appendix A2.1, each TLD is 
subject to a random statistical fluctuation in sensitivity amounting to an uncertainty 
in dose of +/- 2.0%. In measuring central axis depth dose, additional uncertainty 
in dose results from the dose-averaging process which takes place over the depth of 
the TLD. In the dose fall-off region, where dose changes rapidly with depth, this 
effect may be more significant than statistical fluctuations. For a TLD depth of
0.9 mm, the uncertainty in depth with which a given recorded dose actually occurs 
is approximately +/- 0.5 mm.
The purpose of comparing TLD measurements of relative depth 
thermoluminescence with the relative depth ionisation of a diode was to establish
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the significance of systematic errors present in the TLD measurements. Any TLD 
measurements of megavoltage electron fields in a solid phantom are subject to 
systematic errors. The most important of these are the depth dependence of TLD 
sensitivity and the perturbation in dose caused by the presence of the TLDs 
themselves. Scatter effects cause the variation in TLD sensitivity with depth in 
the phantom. At depths in excess of the Dmax depth, the average scatter angle of 
electrons increases, and electrons will, therefore, strike the TLD over a broader 
range of angles. Mobit et al [36] report a maximum variation with depth of 5% in 
sensitivity for LiF 100 TLDs in an electron beam of 5 MeV incident energy. The 
maximum variation decreased to 1% for a 20 MeV beam. Perturbation effects are 
due to the difference in densities of LiF and water. For a higher density material 
such as LiF, there is expected to be a net out-scatter of electrons. As a result, any 
TLD dosimeter situated in a solid water phantom will experience a greater in­
scatter of electrons from other TLDs in the immediate vicinity. If this effect 
varies with energy (and hence depth), an error in relative depth dose measurements 
occurs.
The clinical situations examined in this work involved electron beams with 
incident energies in the range 1 2 - 2 0  MeV and often required TLDs to be 
positioned within 1 . 0  cm of each other, well within the practical range of electrons. 
It is necessary, therefore, to establish that scatter and perturbation effects are 
insignificant or to correct for them. An examination of the data comparing TLD 
measurements with those of a diode reveals that, in the dose fall-off region, the 
depths at which the same normalised thermoluminescence and ionisation occur 
generally agree to within 1.0 mm for the two measurement methods. In the dose 
plateaux, measured dose values obtained by the two methods agree to within 1.5% 
for the 16 MeV beam and to within 2% and 3% for the 6  and 12 MeV beams 
respectively. These differences are within the combined uncertainties of the 
measurements. There is thus no evidence to suggest the presence of a significant 
systematic difference between %depth thermoluminescence and %depth dose.
TLD measurements of relative depth thermoluminescence were, therefore, 
converted to relative depth dose without applying any correction.
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2.5.2 Calculation uncertainties
As well as being dependent on the basic competency of the pencil beam scatter 
algorithm, the accuracy of calculated data is limited by the size of the density and 
calculation grids, and by the number and spacing of the pencil beams. Both TMS 
and Cadplan were set to use calculation grids with a spacing of 2.5 mm. Since 
doses are obtained by an interpolation between grid points, this parameter plays an 
important role in limiting the accuracy with which relative dose can be predicted in 
the dose fall-off region of a %CADD curve.
More fundamentally, %CADD calculations performed by TMS and Cadplan rely 
heavily on the initial dosimetry measurements used to configure the algorithms.
For both planning systems, calculated %CADD depends primarily on an estimate 
of the most probable energy at the phantom surface, Eq. The user provides this 
parameter at the commissioning stage. Eq was estimated by first obtaining a 
measured %CADD curve and extracting the value of R50, the depth of 50% 
absorbed dose, for each beam energy. Values of Eo were then obtained by 
multiplying values of R 5 0  by the conversion factor 2.33 MeV cm“^ as recommended 
by the IPEMB [34]. The last stage of commissioning involves making fine 
adjustments to the values of Eq such that the calculated %CADDs match the 
measured values. Any discrepancy between the treatment planning systems’ 
predictions of %CADD and the measurements performed in this work will, 
therefore, reflect either differences between the commissioning measurements and 
those of this work or an error in the algorithm used to calculate %CADDs based on 
a value of Eo,
2.5.3 Measured and calculated central axis depth doses
There is generally good agreement between TMS and the measured data for 
%CADD. In the dose fall-off region the depth at which a given calculated dose 
occurs is accurate to within 1 . 0  mm at depths greater than the Dmax depth for all 
three beam energies considered (6 , 12 and 16 MeV). In the dose plateaux, doses 
calculated by TMS are within 1% of the measured value in the vast majority of
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cases, and within 2% for the remainder. Cadplan shows a similar degree of 
accuracy in most instances. For the 12 MeV beam there is a small displacement in 
the calculated curve towards shallower depths. The displacement, however, is 
within the measurement tolerance of 1.0 mm and so is insignificant. The most 
problematic area appears to be the shoulder of the depth dose curve where TMS 
underestimates the depth dose by approximately 3% for the 16MeV field.
Cadplan shows a similar error for the 6  MeV field. One possible explanation for 
these errors is the failure of the planning computers to model explicitly electrons 
scattered from the sides of the applicator and cutout. These scattered electrons 
increase the %dose at shallow depths and cause the non-inverse square behaviour 
of electron beams observed at extended SSD [37].
Since the planning systems’ calculations are essentially based on measured data, 
accurate prediction of %CADD does not require a successful implementation of 
the pencil beam scatter algorithm. This aspect of the depth dose calculation is, 
however, required in the prediction of dose distributions arising from the clinical 
beams described in experiments 2-5.
2.5.4 Oblique incidence
The first clinical beam experiment involved a 10 x 10 cm field obliquely incident 
on a plane phantom such that the beam central axis lay at an angle of 30^ to the 
normal to the phantom surface. Oblique incidence effectively reduces the SSD at 
the proximal field edge and increases it at the distal edge. Non-standard SSDs 
change the shape of the beam penumbra (this is discussed further in chapter 3). It 
has also been demonstrated that oblique incidence reduces the vertical depth at 
which the dose maximum and 80% isodose line appear [38].
Both planning systems reproduce the general form of the measured isodose 
distribution produced by the oblique field adequately. The measured and 
calculated data both demonstrate the shift of the central axis dose maximum 
towards the surface. This corresponds closely with the chosen normalisation point 
which, at 2.7 cm along the central axis, has a vertical depth of 2.3 cm. The
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reduction in depth of the 80% isodose line in comparison to the normal incidence 
%CADD data is also apparent in the measured and calculated data.
TMS shows excellent agreement with the measured data in the dose fall-off region 
and is accurate, for the most part, to within 1 mm in the beam penumbra. The 
calculated position of the 10% isodose is, however, only accurate to within 4mm at 
the distal penumbra and 5 mm at the proximal penumbra, TMS placing the line 
closer to the central axis than the measured data in both cases. Qualitatively, this 
is in agreement with Blomquist et al, who reported a 7 mm discrepancy at the low 
dose side of the distal penumbra for a field with 45° angle of incidence [19].
ICRU report 42 [23] states that errors in the dose calculation should amount to no 
more than 2  mm in isodose position in regions of high dose gradient or 2 % of the 
dose in regions of low dose gradient. TMS predictions of penumbra for obliquely 
incident beams must, therefore, be interpreted with caution.
Cadplan predicts the dose fall-off region for the oblique field with slightly less 
accuracy than TMS, consistently underestimating the dose at a given depth. This 
is consistent with the findings of Samuelsson et al [20]. The discrepancy with 
measured data is, however, 2  mm or less and so just acceptable. In the beam 
penumbra, Cadplan predicts isodose position with acceptable accuracy everywhere 
except at the low dose margin. Maximum errors in isodose positions are 2 mm 
and 4 mm for the distal and proximal edges respectively. These are less than the 
discrepancies shown by TMS, though the requirement for caution when 
interpreting penumbra is still necessary.
2.5.5 Bolus edge phantoms
The clinical use of squared-off (90°) bolus edges is usually discouraged because 
electrons scattered from the bolus material create a severe hot spot immediately 
beneath and lateral of the bolus edge. This hot spot is clearly evident in both the 
measured and calculated isodose distributions shown in figures 2.10 and 2.11. A 
measured value of 130% was obtained for the hot spot while TMS and Cadplan 
calculated 119% and 135% respectively. As the volume which actually receives
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the highest dose is very small, the exact value of this dose is of limited clinical 
significance. Of more relevance is the size of the area enclosed by the 105% and 
110% isodose lines. Here there is sufficient qualitative agreement between both 
planning systems and the measured data to make the calculated isodoses a 
reasonably useful prediction of the size of the area receiving the high dose. 
Interpretation of the calculated isodoses requires caution, however. Both planning 
systems, for example, mistakenly portray the 1 1 0 % isodose line extending up to 
the phantom surface when the measured data indicates that it occupies a minimum 
depth of 12 mm. An overestimation of the scatter contribution to relative dose at 
shallow depths behind the bolus edge would explain this error.
To reduce the severity of scatter-induced hot spots, bolus material is often tapered. 
An examination of the measured data from the 45° bolus edge experiment (shown 
in figures 2 . 1 2  and 2.13) indicates that this precaution does indeed reduce the hot 
spot dose. The highest dose measured under the tapered bolus was 114%, 
compared to 130% for the 90° edge. It is notable, however, that use of the tapered 
bolus fails to produce a significant corresponding decrease in the size of the area 
enclosed by the 110% isodose line. TMS agrees closely with the measured value 
of the hot spot while Cadplan overstates the severity of the hot spot by 8 %. TMS 
is also more accurate in its prediction of the size and shape of the regions enclosed 
by the 105% and 110% isodose lines.
2.5.6 Cylindrical air cavity
The last experimental phantom simulated irradiation of the region overlaying the 
trachea. A comparison of the measured and calculated isodose distributions 
shown in figures 2.14 and 2.15 (pages 23 and 24) immediately reveals some 
marked discrepancies. At points lying laterally on either side of the air space, the 
depth of the 95% isodose line is incorrectly calculated by both planning systems. 
This is not related to the presence of the air space and is similar to the error in the 
position of the shoulder of the %CADD curve apparent in the TMS calculation of a 
16 MeV field incident on a plane phantom (discussed above).
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More importantly, both planning computers fail to predict the severity of the hot 
spot lying downstream of the air cavity. The measured data reveals the existence 
of a significant area receiving doses in excess of that at Dmax, with a hotspot of 
107%. The planning computers both show maximum doses of 97%, a 
discrepancy of 10%. There is, in fact, a notable similarity between the dose 
distributions predicted by the two planning computers. Both systems continue to 
underestimate the dose for a considerable depth below the air space. For example, 
at a depth of 15 mm below the downstream edge of the air space, both planning 
systems still underestimate the dose by 10%. This is in broad agreement with the 
findings of Blomquist et a/ [19] for TMS though the maximum underestimation in 
dose reported in this earlier publication was 5%. At greater depth, dose gradients 
are dominated by the general fall-off in dose with depth, and the perturbation 
caused by the trachea becomes less obvious.
2.5.7 Performance of the TMS and Cadplan scatter algorithms
The bolus edge and air space phantoms present difficult tests for the planning 
computers. An accurate calculation of dose in the vicinity of the bolus and air 
space requires detailed modelling of the scatter processes undergone by electrons. 
The scatter algorithms employed by the two planning systems are similar and it 
would seem reasonable, therefore, to expect the two systems to calculate similar 
isodose distributions. This is generally true, with the exception of the hot spot 
values in the bolus edge phantoms. It is important to remember that the pencil 
beam scatter algorithms employed by the planning systems provide only an 
approximation of the multiple scattering events undergone by electrons. The 
scatter contribution which arises from pencil beams depends crucially on the 
values of the parameters chosen to characterise the spread of the Gaussian beams. 
In situations with extreme geometries such as the 90° bolus edge, the calculation of 
hot spots is very sensitive to these parameters’ values and it is unsurprising to find 
discrepancies between the two planning computers and the measured data.
The discrepancies between calculated and measured dose beneath the cylindrical 
air cavity also arise from limitations in the implementation of the pencil beam 
algorithm. Both TMS and Cadplan use a semi-infinite slab approximation to
32
model pencil beams which encounter an inhomogeneity. This model assumes that 
the inhomogeneity has infinite lateral extent. The effects of this assumption were 
considered in detail by Lax [39], who concluded that the resulting failure to model 
the net in-scatter of electrons through the sides of an air cavity could produce a 
significant underestimation of the dose downstream of it. This is consistent with 
the results recorded in this work.
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Appendix A2.1 
Calibration of Thermoluminescent Dosimeters (TLDs)
Dose measurements were made with a batch of 100 TLD dosimeters. To allocate 
an individual calibration factor to each TLD, their relative sensitivity was 
determined by exposing the whole batch to the same dose of radiation and then 
reading each TLD. A mean luminescence reading was calculated for the batch 
and the relative sensitivity of each TLD found by taking the ratio of it’s reading to 
that of the mean. The average relative sensitivity in the batch is, therefore, exactly
1 .
This entire process was performed six times and a mean of the six resulting relative 
sensitivities calculated for each TLD. These values were used as the calibration 
factors in subsequent measurements. The distribution of mean TLD sensitivities is 
shown below:
TLD Individual Calibration
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Figure A 2.1. Frequency distribution o f the relative sensitivity of 100 LiF 100 TLD dosimeters used 
in the measurement of 2D isodose distributions in WTe solid water.
The percentage standard deviation in the six values of relative sensitivity was now 
calculated for each TLD. This figure gives an indication of the reproducibility of
measurements made with the corresponding TLD. For the entire batch, the mean
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value of the percentage standard deviation, S, was 1.0%. Since the material, 
volume and shape of the TLDs are very similar, there is no reason to suppose that 
the true standard deviation varies between TLDs and so this mean figure was 
regarded as indicative of the reproducibility in sensitivity for each of the TLDs.
The standard error of subsequent TLD measurements is given by the expression
SE = (s^/p + S^/q + S^/m y^  (1)
Where S  is the standard deviation in the sensitivity of one TLD, p  is the number of 
chips used to provide an absolute dose calibration, q is the number of chips used 
for the measurement in question, and m is the number of times the sensitivity of the 
given chip was assessed during the initial calibration process.
For relative dose measurements, the first term in equation (1) can be omitted. The 
respective values of q and m werel, and 6 , for this work. Equation (1) then gives 
a value of 1 . 1  % for the standard error in a single measurement of 
thermo luminescence.
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Appendix A2.2
Flow diagram of Microsoft Excel Visual Basic routine used for conversion of
TLD point doses to isodose lines.
This routine operates on measured data residing in the first 3 columns of an Excel 
spreadsheet. The program processes this data and deposits the results in the same 
spreadsheet from column 15 onwards. Isodose plots are produced by using the 
processed data as input to the Excel graphs routine. Program variables in italics.
Get isodose values to be plotted from user.
Put interpolated position, original depths and 
interpolated dose data in spread sheet 
columns 10,11,12.
Generate linearly interpolated doses for 9 
positions between each measured value.
Get measured profile position, depth and 
dose from spread sheet columns 1,2,3. 
Get interval between successive positions.
Set position variable to lowest measured 
value.
Set depth variable to 0.
Set isodose to first value selected by user. 
Set active cell in spread sheet to 
column 15, row 1.
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NO.
Increment depth
NO.
Increment
position
NO.
Last isodose value reached ?
YES.
Set depth = 0
Increment isodose value
NO.
Maximum depth value reached ?
Maximum position value reached ?
Do successive dose values imply existence of 
isodose value in given depth interval ?
For next 1mm interval of position , compare doses at 
successive depths with isodose value .
Re-set position to lowest measured 
value.
Increase sheet active column by 2
YES.
YES.
Produce isodose plot using cells 
from column 15, row 1 onwards 
as input to Excel xy scatter plot. 
Successive pairs of columns 
represent successive x and y 
series.
YES.
Calculate interpolated depth 
at which isodose value arises. Store 
{position, interpolated dose ) in neighbouring 
cells in spread sheet active row. 
Increment active row.
CHAPTERS 
BEAM PENUMBRA AT EXTENDED SSD
3.1 Introduction
The use of megavoltage electrons in the treatment of cancers of the head and neck 
is well established [2, 40 -  42]. Single field electron treatments are often useful 
for superficial lesions, while a combination of electron and photon fields are used 
for deeper lesions. In this latter case, lateral parallel opposed photon fields are 
often used to irradiate the primary disease until spinal cord tolerance is reached. 
The margins of the photon field are then moved anteriorly and an abutting electron 
field introduced to treat the cervical nodes. Dose homogeneity in the junction 
region is often an important consideration, and therefore the penumbra 
characteristics of abutting electron and photon beams require careful examination 
[43 -  45]. Unfortunately, the tendency of patients’ shoulders to interfere with the 
electron applicator often necessitates treatment be given at extended SSD, and so a 
knowledge of the electron beam’s penumbra at both standard and extended SSD is 
necessary.
It has been noted before that the penumbra characteristics of electron beams do not 
conform to the inverse square law [46,47]. This is due to the contribution of 
scattered electrons from the applicator, cutout and air column to the beam fluence 
at the phantom surface. The way in which scatter affects the relation between 
SSD and dose on the beam central axis has been previously modelled by use of a 
virtual source position [31,37,48]. This approach, however, has limitations. The 
virtual source position is machine specific and varies with energy and field size. 
Moreover, it has proved to be an inadequate description of the way penumbra 
location and width are affected by SSD, and alternatives such as Target Coverage 
Factor (TCP) have been proposed [49].
Both the Helax TMS and Varian Cadplan treatment planning computers implement 
a form of the virtual source approximation in their description of electron beam 
behaviour at extended SSD. Parameters affecting the width and position of the
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penumbra at 100 cm SSD are defined by the user at the commissioning stage.
Beam penumbra at extended SSD is modelled by a theoretical extrapolation of 
these parameters. Explicit measurements of the beam profile are not used by 
either planning system. This study compares the computers’ prediction of 
electron beam penumbra at standard and extended SSD with measured data and 
assesses the optimum relative position of abutting photon and electron fields in 
clinical situations.
3.2 Materials and Methods
3.2.1 Electron beam set-ups
Measured and calculated dose profiles were obtained for a 10 x 10 cm field size 
(defined at 100 cm SSD). SSDs of 100, 105, 110 and 115cm were considered, the 
latter figure representing the largest SSD considered acceptable for clinical use at 
the Beatson Oncology Centre. Measured doses were compared with those 
calculated by Helax TMS v4.0A and Varian Cadplan v2.7.9. A calculation grid 
spacing of 1 . 0  mm was used for both computers.
Exposures were made with a Clinac 2100C linear accelerator (Varian Associates, 
as before) capable of producing electrons with energies 6 , 9,12,16 and 20 MeV. 
Cutouts were housed in a 10 x 10 cm applicator designed such that the distance 
from the physical electron source to the mid depth of the cutout was 94.0cm. The 
applicator accepts field-defining cutouts constructed of low melting point ostalloy. 
At the Beatson Oncology Centre these have a thickness of 11mm irrespective of 
the electron energy in use. An interlock prevents operation of the accelerator 
unless a cutout is in place. To achieve a 10 x 10 cm field size, therefore, a square 
annulus of ostalloy with inner dimensions of 10 x 10 cm at 100 cm SSD is used 
with the nominal 1 0  x 1 0  cm applicator.
3.2.2 Measurement apparatus
Measurements were made with a diode in a water phantom. Solid state dosimerty
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has been shown to be an ideal method of relative dose measurement in electron 
beams [50,51]. In comparison to ion chambers, the signal to noise ratio is very 
high as a result of the high sensitivity of diodes. Of particular relevance to 
penumbra measurements are diodes’ comparatively small active volume and 
therefore high spatial resolution. The detector used in this work was a 
Scanditronix n-Si diode (QADOS Ltd, as before). This is a n-type detector with a 
sensitive volume of 0.3 mm^ and an effective detection area of 2.5 mm diameter. 
The device was interfaced to a Therados DPD5 electrometer (Therados Instrument 
AB, Dalgatan 15, Uppsala, Sweden).
During measurements, the diode was situated in a polymethylmethacrylate 
(PMMA) cylindrical holder of thickness 2.5 mm, which could be moved along an 
axis perpendicular to the beam central axis. The water phantom containing this 
holder had dimensions of 40 x 40 x 40 cm, and was designed to be irradiated 
through its 5 mm PMMA side using a gantry angle of 90° or 270°. This 
arrangement is shown in figure 3.1.
5 mm
Diode
>
electrons
w
2.5 mm
PMMA
Figure 3.1. Arrangement of water phantom and diode for electron beam profile measurements. 
Electrons traverse 5mm of PMMA before entering water, then a further 2.5 mm of PMMA before
reaching the diode detector.
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Before entering the water, beams were thus subject to 5 mm of PMMA and later 
traversed 2.5 mm of PMMA before entering the detector. A total thickness of 7.5 
mm of PMMA was therefore traversed by the electron beam for all measurements. 
Using a value of 1.15 for the ratio of the electron density of PMMA to that of 
water, and making the assumption that the mass stopping powers of PMMA and 
water are approximately equal [31], it is evident that this thickness is equivalent to 
approximately 8.7 mm of water. The depth of water between the phantom wall 
and PMMA holder was varied according to the electron energy such that the total 
water equivalent depth was approximately equal to the depth of dose maximum at 
100 cm SSD for each energy. These total depths were 1.5cm for 6MeV beams, 
2.1cm for 9 and 12 MeV and 1.7cm for 16 and 20 MeV.
3.2.3 Diode measurements
Before commencing profile measurements, the linearity of the diode’s response to 
absorbed dose was established for electron beam energies of 6 and 16 MeV. This 
was achieved by comparing diode readings with absorbed dose as detected by the 
ion chambers of the linear accelerator. The results are shown in appendix A3.1. 
Interestingly, there is a small difference in the ratio of diode reading to monitor 
units for the two energies. This is more likely to reflect energy dependence in the 
response of the diode than it is to reveal a calibration error in the accelerator 
monitor chambers. The linearity of diode response for beam energies 6 and 16 
MeV was assumed to imply a linear response at the other available beam energies.
Prior to each set of measurements, the water phantom (with diode in situ) was left 
in the accelerator room for a period of at least 1.5 hours to achieve temperature 
equilibrium. Measurements were made using a gantry angle of 90°. Electron 
beam profiles were obtained by measuring at a series of discrete points along an 
axis perpendicular to the beam central axis and to the plane of rotation of the 
accelerator gantry (this corresponds to the photon collimator Y axis). 
Measurements were made at beam energies 6, 9, 12, 16, and 20 MeV and at SSDs 
in the range 100 cm to 115 cm. Each measurement was repeated 3 times and an 
arithmetic mean taken. To reduce systematic errors due to variations in machine
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output and diode sensitivity (the latter caused mainly by temperature fluctuations), 
the central axis dose was re-measured after every three off-axis measurements.
For the measured data, target coverage factors (TCFs) have also been calculated 
according to the definition given by Das et al [52]
TCF(n) =
W 5 0
Where Wn is the width of the n% isodose line at a given SSD and W50 is the 
geometric field width at 100 cm SSD. Widths are measured at the depth of dose 
maximum. TCF(90), for example, represents the ratio of the width of the 90% 
isodose line to the geometric field size.
3.2.4 Abutting photon and electron fields
To assess the junction region between abutting photon and electron beams, 
electron beam profiles were added to photon beam profiles measured separately. 
Two beam set-ups were considered. Both set-ups consisted of isocentric parallel 
opposed 6  MV photon fields measuring 10 x 10 cm at their isocentre, abutted to a 
single fixed SSD electron field having dimensions 10x10 cm at 100 cm SSD.
For the first beam set-up, a SSD of 100 cm was used for the electron field. The 
second set-up modelled extended SSD treatments by using a SSD of 110 cm for 
the electron field. The beam set-ups are shown in figure 3.2.
For each beam set-up two photon dose profiles were obtained. Each was 
measured at a photon Focus to surface distance (FSD) of 92.0 cm, the first at a 
depth in water of 2.0 cm and the second at a depth of 14.0 cm. The measurement 
protocol for obtaining relative off-axis doses was the same as that described above 
for electrons. Adding doses from the corresponding off-axis points of the two 
profiles results in a combined profile equivalent to that which would be obtained 
by a single measurement at 2 . 0  cm depth in a phantom of total separation 16.0 cm 
exposed to parallel opposed photon fields with a common isocentre at the mid
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point of the phantom and a source to isocentre distance of 100.0 cm. A separation 
of 16 cm is typical of those encountered clinically in neck irradiations.
The photon and electron profiles were assigned relative weighting factors such that 
the dose delivered by the electron field to the depth of dose maximum on its 
central axis was the same as that delivered by the combined photon fields to their 
isocentre. A weighted sum was then calculated to yield the combined photon and 
electron beam profile resulting from abutting fields. Profiles were combined by 
firstly selecting a notional distance between photon and electron beam central axes. 
Photon and electron doses at corresponding points were then summed to yield the 
combined profile. The size of the gap which would appear between the light field 
edges of abutting photon and electron field edges is determined by the relative 
position of the central axis of the two fields. Adding profiles such that a point 
50 mm from the photon central axis coincides with a point 50 mm from the
50mm46mm
electronsphotons
Figure 3.2. Field edge positions for abutting isocentric photon and fixed SSD electron fields at the 
surface of a 16 cm separation phantom. Central axis separation o f 100 mm. Photon isocentre is
at a depth o f 8 cm.
electron central axis is equivalent to a gap of 4 mm at the phantom surface for a 
100 cm SSD electron field, as illustrated in figure 3.2.
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3.3 Results
Figures 3.3 -  3.7 show beam profiles for electron energies from 6 to 20 MeV. At 
each energy, measurements are compared with data calculated by the TMS and 
Cadplan planning computers. In each case, 7 position represents distance from 
the beam central axis and % dose represents the ratio of the off-axis dose to that on 
the central axis. Measurements and calculations were made at, or near, the depth 
of dose maximum for each energy. These depths were 1.5 cm for the 6 MeV field,
2.1 cm for the 9 and 12 MeV fields and 1.7 cm for the 16 and 20 MeV fields.
Since the field defining cutouts are symmetrical, only one half of the profile was 
recorded.
Target Coverage Factors for the 10%, 50% and 90% isodose lines resulting from a 
single electron field have been calculated from the measured data and are shown in 
figure 3.8. Trend lines describing the relation between TCF and SSD are 
displayed. These have been extrapolated 5 cm beyond the shortest and longest 
SSD at which measurements were made. The justification for this is given in 
section 3.4 (Discussion). TCF(IO), indicative of the area enclosed by the 10% 
isodose line, increases more rapidly with SSD than TCF(50) or TCF(90).
Generally, TCF(90) varies very slowly with SSD, indicating that the useful 
treatment area is not increased by increasing the beam’s SSD.
Figure 3.9 shows measured dose profiles across the junction region for abutting 
photon and electron fields. Clinically, the most commonly encountered energies 
are 9, 12 and 16 MeV. For each of these, electron field SSDs of 100 cm and 110 
cm are considered. In each case, the electron field central axis is located at 
position “0” on the horizontal axis. The electron and photon fields are, therefore, 
on the left and right of the junction respectively. Separately measured photon and 
electron fields were manually added to produce the final profile. During this 
process the size of the gap between photon and electron light field edges was 
varied in order to find its optimum length. The optimum gap size was taken as the
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Figure 3.8. Target Coverage Factors (TCF) factors for electron beams o f energy 6 - 2 0  MeV. 
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Figure 3.9. Dose profiles at the Dmax depth for a 16 cm separation phantom irradiated with 
isocentric parallel opposed photon fields abutted with a single fixed SSD electron field. Electron 
fields are to the left o f the junction. Electron energies of 9, 12 and 16 MeV are shown. Photon 
energy is 6 MV. Gaps between the fields are the optimum sizes shown in table 3.1
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Electron Energy (MeV) Electron field SSD Optimum gap (mm)
16 100 4
16 110 3
12 100 4
12 110 3
9 100 4
9 110 1
Table 3.1. Optimum gap sizes for a 16 cm separation phantom irradiated with isocentric parallel 
opposed photon fields abutted with a single fixed SSD electron field. Gap sizes are the distances
between light field edges.
largest gap which resulted in the minimum dose across the profile being no lower 
than 90% of the maximum dose on the electron central axis. A minimum of 90% 
dose was chosen because this is often the minimum dose specified in treatment 
prescriptions. Table 3.1 gives a summary of the optimum gap sizes. Using an 
upper limit to the minimum junction dose as the basis for field gap selection has 
potentially undesirable consequences for the maximum dose across the junction. 
Hot spot doses of 120% are evident for the 9 MeV extended SSD junction, and for 
the 16 MeV standard SSD junction.
3.4 Discussion
This work has involved the acquisition of dose profiles for a 10 x 10 cm electron 
beam at standard and extended SSD. Beam energies of 6,9, 12, 16 and 20 MeV 
have been considered for SSDs in the range 100 -  115 cm. Measurements made 
with a diode in a water phantom have been compared to calculated data generated 
by two treatment planning computers: Helax TMS and Varian Cadplan. Data has 
been presented in graphical form as plots of dose against Y axis distance and as 
plots of Target Coverage Factor (TCF) against SSD. TCF provides an indication 
of how the area covered by an isodose line varies with SSD. Finally, dose profiles
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in the junction region of abutting electron and photon fields have been obtained for 
both standard and extended SSD treatments.
3.4.1 Uncertainties in measured and calculated doses
Both the measured and computed dose profiles are subject to limitations in their 
accuracy and reproducibility. Measurements were made with a diode detector 
which could be positioned with an estimated uncertainty of +/- 0.25 mm. The 
precision in measuring the position of an isodose line was thus no better than +/- 
0.25 mm. The final precision in isodose position is also affected by the accuracy 
of dose detection. Since measurements were taken in a region of rapidly changing 
dose, accuracy was limited by the size of the active volume of the detector. The 
diode used in this work had an active volume of diameter 2.5 mm. In the 
penumbra region, absorbed dose may vary by as much as 60% over this distance, 
dependent on beam energy and SSD. The accuracy of the measurement is thus 
compromised by the resultant dose averaging process which occurs over the 
detector volume.
Diode measurements are also subject to statistical fluctuations in the amount of 
charge collected for a given dose. It is likely, however, that at the levels of 
absorbed dose used in this work, these fluctuations are insignificant [50]. It is 
difficult to quantify the total uncertainty in accuracy but it would seem reasonable 
to assume that the error imposed by the dose-averaging process combined with the 
inherent uncertainty in detector position leads to an overall uncertainty in measured 
isodose line position of +/- 1.0 mm in the penumbra.
The computed data has a spatial resolution limited by the calculation grid spacing: 
in this case 1.0 mm. The accuracy of the computed data is determined by the 
number and spacing of the pencil beams used to model electron scatter in the 
phantom and by the accuracy with which the electron fluence profile at the 
phantom surface is defined. The fluence profile is dependent on machine specific
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parameters such as scattering from the photon collimators, applicator and cutout, 
and on the distance from the cutout to the phantom surface.
3.4.2 Calculation algorithms
Neither the TMS nor Cadplan systems explicitly model electron scattering in the 
machine head. To describe electron behaviour in extended SSD fields, both 
systems use the concept of an energy dependent root mean square scattering angle, 
0rms, of the in-air electron fluence. This parameter describes the extent to which 
the average angle of travel of a given electron deviates from the direction of the 
beam central axis. The TMS and Cadplan physics manuals both recommend Grms 
be selected by the user at the commissioning stage. Neither manufacturer suggests 
explicit values for the parameter; the values used in this work were based on those 
recommended by Lax [53]. These were then adjusted such that the calculated 
penumbra shape matched the measurements as closely as possible at 100 cm SSD. 
A typical value for Grms was 0.025 radians for a 9 MeV beam.
In TMS, the value of Grms at the phantom surface is combined with a radial 
broadening parameter, rgap, to define the angular and radial spreading of the pencil 
beams at depth in the phantom. A theoretical algorithm first described by Lax and 
Bramhe [28] is used to increase the values of Grms and rgap in proportion to the 
distance from the cutout to the phantom surface, and is the mechanism responsible 
for broadening beam penumbra at extended SSD,
TMS calculates the position of the centre of the penumbra (the 50% isodose line) 
by referring to an algorithm based on data from a set of Full Width at Half 
Maximum (FWHM) measurements made by the user at the commissioning stage. 
The literature accompanying TMS recommends FWHM measurements are made 
on a 20 X 20 cm field size at 100 cm and 110 cm SSD, for each electron energy. 
This data allows TMS to calculate, for each beam energy, a virtual source position 
(VSP). It is assumed that the VSP is independent of field size. In modelling
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electron beams at extended SSD, the 50% isodose position is found by applying an 
inverse square expansion based on the VSP for the appropriate energy. TMS 
should, therefore, predict with reasonable accuracy, the position of the 50% 
isodose line for electron beams of SSD up to and including the FWHM 
measurement value of 110 cm.
The theory adopted by Cadplan to increase the angular and lateral spreads of pencil 
beams at depth is, like TMS, based on the work of Lax [53]. There is an important 
difference in the method used to predict the centre of the penumbra, however. 
While TMS bases its calculation on measured FWHM data, Cadplan defines the 
50% isodose line position entirely theoretically according to a formalism 
developed by Huizenga and Storchi [54]. Pencil beams are assigned a weighting 
according to whether or not their central axis traverses the field defining cutout.
The weighting factor may have one of only two values: full weighting (for pencil 
beams not traversing the cutout), or a weighting reduced by the transmission factor 
of the cutout.
3.4.3 Comparison of measured and calculated doses
An examination of the measured and calculated field profiles reveals that the 50% 
isodose position is predicted accurately by both TMS and Cadplan. For all beam 
energies the calculated and measured positions of 50% dose lie within 2 mm 
throughout the range of SSDs considered i.e. within the combined uncertainties of 
the measured and calculated values. A real discrepancy in isodose position of up 
to 2 mm is generally regarded as acceptable accuracy [23]. Since TMS bases if  s 
calculation on measured data, the small discrepancies between its calculations and 
the measurements are likely to result purely from minor systematic differences 
between the commissioning measurements and those performed for this work.
The success of the alternative theoretical approach to predicting 50% isodose 
position adopted by Cadplan is confirmed by the similarity of the Cadplan 
predictions with those of TMS and the measurements.
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The positions of the low and high dose edges of the penumbra are predicted with 
less accuracy by the planning computers. It is notable that, for both systems, 
modelling of electron interactions in the field-defining cutout is limited to a 
modification of the effective beam weight to account for the transmission factor of 
the cutout. No attempt is made to account for the increased scattering power of 
the cutout material. The resulting increase in 0rms for electrons transmitted by the 
cutout is, therefore, neglected. It is thus reasonable to expect that pencil beam 
broadening will be under-estimated by the planning computers and that there will 
be a consequent under-estimation of penumbra width. This effect should not be 
apparent at the standard SSD of 100 cm since Grms is selected by the user to match 
the measured penumbra, but a significant effect may be expected at extended SSD 
as the scattered electrons have a greater distance to traverse before reaching the 
phantom.
There is clear evidence that the calculated isodose positions at the far (low dose) 
edge of the penumbra are consistent with this failure to predict penumbra 
broadening. For Cadplan this trend is particularly notable at 115 cm SSD. With 
the exception of the 12 MeV beam, the calculations consistently place the 10% 
isodose line inside the measured position. Generally the discrepancy is 
approximately 4 mm but for the 6 MeV beam it is 9 mm. A similar trend is 
apparent at 110 cm SSD though here Cadplan’s calculations are more accurate: the 
maximum discrepancy from measured data is 4 mm. The TMS calculations at the 
far penumbra edge show similar trends to those of Cadplan without exhibiting as 
large a discrepancy at 6 MeV. The maximum discrepancy from the measured data 
is 5 mm, again at 6 MeV and 115 cm SSD.
It is evident from a general examination of the beam profiles that the higher energy 
beams (16 and 20 MeV) are modelled with greater accuracy by both planning 
systems. This is particularly true at the high dose (near) side of the penumbra at 
extended SSD. At extended SSD, both systems trend towards greater 
discrepancies for the 6, 9 and 12 MeV beams. The calculated position of 90% 
dose is consistently placed further from the beam central axis than its measured 
position. Cadplan exhibits the greater discrepancies from the measured data: up to
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6 mm for a 9 MeV beam at 115 cm SSD. The tendency for both systems to 
overestimate the distance from the beam central axis to 90% dose is again 
consistent with a failure to predict penumbra broadening. The fact that this effect 
is more pronounced at lower beam energies (for which the scattering power of the 
cutout is increased) is further evidence for the planning systems’ underestimation 
of Grms for electrons transmitted through the cutout.
For the 9 MeV field, a trial and error approach revealed that the value of Grms 
stored in Cadplan had to be doubled from 0.025 radians to 0.05 radians to achieve 
a match between the measured and calculated penumbra at 115 cm SSD. Making 
this change, however, had the undesirable effect of broadening the beam penumbra 
at 100 cm SSD to an unacceptable size.
3.4.4 Target Coverage Factors (TCFs)
It is notable that both planning systems consistently produce errors in isodose 
position of considerably more than 2 mm at the near and far sides of the penumbra 
at extended SSD. Calculated isodose distributions in the penumbra must, 
therefore, be interpreted with extreme caution. If an estimation of isodose position 
at extended SSD is required clinically, a more realistic approach may be to 
examine the measured TCF factors.
TCF(90) is likely to be most useful for this purpose, as dose prescription is often to 
90% dose for electron treatments. It is interesting to note that TCF(90) varies very 
slowly with SSD. For beam energies 6-12 MeV its value either increases slowly 
or remains static with increasing SSD. At 9 MeV, for example, TCF(90) remains 
in the range 0.87 -  0.84 for SSDs between 100 and 115cm SSD (inclusive). This 
corresponds to a range of 87 mm -  84 mm of 90% coverage at the Dmax depth, 
irrespective of SSD. There is, on the other hand, a small increase in the value of 
TCF(90) with SSD for 16 and 20 MeV beams. At 20 MeV the increase is 
monotonie and in the range 0.97 to 1.05. These findings contradict those of Das et 
al [49] who predicted a decrease in TCF(90) with increasing SSD for all beam 
energies.
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A possible explanation for the discrepancy between these results and those of Das 
et al may lie in the shape of applicator used with the Clinac 2100C linear 
accelerator. The applicators used in this work have a rectangular cross-section 
throughout their length. Das et al report using cone-shaped applicators. Since 
applicator design is a significant factor in determining scattering and beam profile, 
it is perhaps not surprising to find differences in TCF factors.
While TCF(90) is a static or slowly varying function of SSD, TCF(IO) shows a 
rapid expansion. At the 6 MeV beam energy TCF(IO) increases from 1.18 to 1.59 
on moving from 100 cm to 115 cm SSD. This corresponds to an additional 4.1 cm 
in the width covered by the 10% isodose line at Dmax. At 12 MeV TCF(IO) 
increases from 1.18 at 100 cm SSD to 1.38 at 115 cm. The TCF graphs clearly 
illustrate the diverging path of the 90% and 10% isodose lines as SSD is increased, 
and further illustrate the penumbra broadening which occurs at extended SSD.
The difference between TCF(IO) and TCF(90) is most pronounced at the lower 
beam energies. At the higher beam energies of 16 and 20 MeV, the differences are 
smaller but the divergence of the trend lines for the two factors is still very 
apparent as the SSD is increased.
At the 16 and 20 MeV energies, extrapolation of the trend lines in TCF to SSDs 
below 100 cm reveals that all values of TCF converge as the SSD approaches a 
value slightly less than 95 cm. For the 2100C accelerator, the distance from the 
electron source to the end of the applicator is 94 cm. The convergence of TCF 
factors near this point for the higher beam energies implies that beam penumbra 
would shrink to virtually nothing were the applicator brought in contact with the 
phantom surface (giving an SSD of 94 cm). This is perhaps not surprising since 
the penumbra results largely from the effects of scatter at the edge of cutout. The 
scattering power of ostalloy is reduced significantly at higher beam energies.
With no air gap to allow beam spreading, a step change in beam fluence from open 
to closed field would result.
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3.4.5 Abutting photon and electron fields
The uniformity of the dose distribution which results from adding an electron field 
to photon fields depends critically on the nature of their respective penumbra 
profiles and will, therefore, depend on the SSD of the electron field. This is 
shown clearly in the graphs which display summed dose profiles for isocentric 
photon fields in combination with electron fields at 100 cm and 110 cm SSD. For 
the 9 and 12 MeV electron fields, dose uniformity in the junction region is 
significantly reduced on moving from 100 cm to 110 cm SSD. Uniformity is poor 
at extended SSD because the electron field’s penumbra is much broader than that 
of the photon fields. There is a characteristic hot spot on the photon side of the 
junction due to scattered-in electrons and a corresponding cold spot on the electron 
side due to scattered-out electrons not being balanced by scattered-in photons.
An interesting reversal of this trend occurs at 16 MeV where the 110 cm SSD field 
produces the better summed profile. This may be attributed to the fact that, at 100 
cm SSD, the 16 MeV electron field has a narrower penumbra than the photon 
fields. The expanded penumbra at 110 cm SSD provides a better match for the 
photon fields.
It should be noted that the optimum gap sizes shown in the results refer only to 
profiles at the Dmax depth. Dose uniformity at greater depth may differ 
significantly from that shown at the Dmax depth, particularly for the higher energy 
electron fields where the dose plateaux extends far beyond the Dmax depth. 
Unfortunately, the limitations of treatment planning computers in modelling 
electron penumbra at extended SSD (as discussed above) make a detailed 
assessment of the depth dose distribution in the plane normal to the junction region 
rather difficult. Johnson and Khan [55] measured 1-dimensional dose profiles 
resulting from abutting photons and 9 MeV electrons at standard and extended 
SSD and found similar patterns of hot and cold spots to those described in this 
work. Computer modelling with a commercial planning system of the 2-D 
distribution failed, however, to predict the extent of the hot and cold spots.
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The preceding discussion should illustrate that the decision to use an abutting 
photon and electron treatment technique requires careful consideration. Treating 
with a gap any larger than the optimum size indicated here will lead to regions 
where the dose falls below 90%. This is unacceptable if the junction region is 
regarded as part of the clinical target volume. The hot spots of 120% dose 
resulting from the use the optimum gaps in matching photons with electron fields 
of energies 9 MeV (at 110 cm SSD) 16 MeV (at 100 cm SSD) are undesirable. 
These hot spots may be acceptable clinically, however, if they occur over a small 
volume of sub cutaneous tissue. This will be true of the 9 MeV field but not 
necessarily of the 16 MeV beam where the hot spot is likely to extend to greater 
depth. For 16 MeV electrons the optimum clinical technique may be to treat at 
extended SSD in order to achieve better penumbra matching at the junction.
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Appendix A3.1
Dose response characteristics of measurement diode
6 MeV Beam Energy: 16 MeV Beam Energy:
Measurement Depth = 1.5 cm water equivalent Measurement Depth = 1.7 cm water equivalent
Dark current corrected to zero Dark current corrected to zero
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Figure A3.1. Dose response o f P-type diode detector for 6 and 16 MeV electron fields.
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CHAPTER 4 
BEAM PROFILES WITH OSTALLOY CUTOUTS
4.1 Introduction
In the majority of therapeutic electron treatments, secondary collimation of the 
beam by means of an applicator arrangement is necessary to produce acceptable 
beam uniformity and to maximise electron fluence at the patient surface. Field 
shaping to reduce the dose to adjacent normal tissue is then often achieved by the 
addition of lead or low melting point alloy apertures, or cutouts, to the end of the 
applicator [56-58]. It has been noted [12] that the angular spread in electron 
momentum caused by multiple scattering at the accelerator head, applicator side 
walls and cutout leads to a gradual reduction in electron fluence in the region of the 
cut-out edge, giving rise to a characteristic penumbra.
Various workers have investigated the nature of the penumbral region by 
measuring or deriving dose profiles in phantoms resulting from electron fields used 
with secondary collimation [58,59]. Al-Ghazi et al [60] found that the penumbra 
width increases with energy but is virtually independent of field size. Sabbas et al 
[61] have modelled the characteristics of the penumbra based on the angular spread 
of electron moments at the collimators and contend that the width and position of 
the penumbra depends crucially on the electron energy and the design of the 
accelerator head, applicator and cutout.
In this study, the position of the 90% isodose line in relation to the cutout edge is 
examined for various cutout shapes. In selected cases an assessment of the 10% 
isodose line is also made, allowing penumbra width to be estimated. Among the 
cutout shapes investigated are the range of ellipses used to give electron boost 
fields to the resection sear area in patients who have undergone breast lumpectomy 
or wide local excision. The efficacy of electron boost techniques is well 
established [5, 62-64], though concern has been expressed over the accuracy and 
precision with which these treatments are prescribed [65,66 ]. As with any
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external beam radiotherapy treatment it is advantageous for the clinician to 
prescribe a defined minimum dose to a defined region rather than define only the 
physical edges of a field shaping aperture [67]. This work has established the 
extent of the 90% dose region in a single plane perpendicular to the beam axis 
using film dosimetry and compared the results with calculated profiles from a 
Helax TMS planning computer.
TMS is able to accept detailed specifications of cutout geometry, entered in a 
beam’s eye view. This data is then used to modify the energy fluence matrix 
which, in turn, is convolved with pre-calculated dose kernels to yield dose within 
the phantom under consideration [12]. The algorithm can, therefore, model cutouts 
of arbitrary shape.
A full assessment of the calculated penumbra requires comparison with 
measurements made in a plane perpendicular to the beam central axis. Film 
dosimetry has clear advantages in speed and ease of use over other methods when 
large 2-dimensional dose distributions require to be obtained. Moreover, its 
accuracy has been established by innumerable studies [31,48,68-70] which 
conclude that, under controlled conditions, the relationship between net recorded 
optical density and absorbed dose to the phantom (the sensitometric curve) is 
independent of electron energy and is generally one of direct proportionality.
This proportionality cannot be assumed for photons, however, due to the energy 
dependence of the photoelectric and Compton cross-sections for photon 
interactions in the film [71,72]. Any electron beam which interacts with metallic
objects such as the primary collimators, applicator side walls or alloy cutout will 
inevitably give rise to bremsstrahlung radiation [73,74] which, in turn, contributes 
to the total absorbed dose received by objects in the beam. It is likely that 
proportionally greater dose is contributed by bremsstrahlung near the applicator 
and cutout side walls [75] and therefore the optical density recorded by film in this 
region cannot be assumed to be directly proportional to absorbed dose.
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4.2 Materials and Methods
4.2.1 Field set-up
Isodose profiles were produced for a plain 10x10 cm ostalloy cutout together with 
the range of elliptical cutouts currently regarded as having maximum clinical 
utility for breast boost treatments.
Exposures were made with a Clinac 2100C linear accelerator (Varian Associates, 
as before). An applied dose of approximately 45 cGy to the point of maximum 
central axis dose was used for all exposures. The applicator accepts field defining 
cutouts constructed of low melting point ostalloy which, in the Beatson Oncology 
Centre, have a thickness of 11 mm irrespeetive of the electron energy in use.
Both plain and ellipical cutouts were housed in a 10 x 10 cm applicator designed 
such that the distance from the physical electron source to the mid depth of the 
cutout was 94.0cm An interlock prevents operation of the accelerator unless a 
cutout is in place, and so plain 10 x 10 cm inserts must still be used to achieve this 
field size.
Dose profiles were recored by placing film in a TEMEX [76] water-equivalent 
solid phantom in a plane perpendicular to the beam central axis. For all 
exposures, the distance of the electron source to the phantom surface (SSD) was 
100 cm. Films were placed at or near the depth of dose maximum. In all cases, 
Kodak XV2 therapy verification film was used (Eastman Kodak Company, 
Rochester, New York 14650, USA). This film has a linear sensitometric curve 
over the range of absorbed dose considered here [48]. All films were from the 
same batch and were processed under similar conditions in an automatic film 
processor.
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4.2.2 Corrections to the measurements
Films were read with a transmission scanning densitometer capable of recording 
optical density along 1 -dimensional tracks across the film. The scanner was 
capable of resolving areas of raised or lowered optical density with diameters of 
1mm or greater. Measurements of absorbed dose using this film and densitometer 
combination were found to be reproducible and of sufficient precision to record 
single monitor unit increments (see appendix A4.1.).
The difficulties associated with the bremsstrahlung contribution to optical density 
near the cutout edges were overcome by comparing films with diode measurements 
for a plain 10 x 10 cm cutout. Diode measurements were made in a water 
phantom using a p-type detector interfaced to a Therados DPD5 electrometer 
(Therados AB, Dalgatan 15, Uppsala, Sweden). Measurement depths at each beam 
energy were chosen to correspond to those used for film measurements. The 
measurement axis was in the plane of rotation of the accelerator gantry and 
perpendicular to the beam central axis (this corresponds to the direction of the 
collimator X axis when collimator angle 0° is set). The distance from the field 
centre to the point receiving 90% of the absorbed dose to the central axis was noted 
for the plain cutout at each available energy. Returning to the films, optical 
density was now measured at the corresponding X axis displacement from the field 
centre on the film and this optical density, labelled O D 9 0 ,  was henceforth assumed 
to correspond to 90% of the central axis dose wherever it occurred on the film. A 
similar methodology was applied to obtain the position of regions corresponding to 
10% of central axis dose.
The equivalent squares of the six breast boost cutouts examined in this work were 
all within the range 6.0 -  7.3. As long as the applicator size and design remain 
fixed, outputs (in monitor units per Gy) for electron fields show very little variation 
over this range of equivalent square. Provided, therefore, the same number of 
monitor units are applied to the breast boost cutouts, O D 9 0  can be regarded as
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representing 90% of the central axis dose at the same depth for the breast boost 
cutouts.
Isodose profiles were also generated by a HELAX TMS planning computer. 
Profiles were calculated for plain and breast boost cutouts for beams incident on a 
homogeneous water-equivalent phantom. Dose calculation was to a matrix of 
points separated by 2.5mm.
4.3 Results
4.3.1 The 10 X 10 cm cutout
Table 4.1 gives two X axis displacements, X90 and Xio. These are the mean 
distances from the central axis at which, respectively, 90% and 10% of the central 
axis dose occur for the 10 x 10 cm cutout. For each beam energy, measurements 
were made at a single depth with a diode in a water phantom. Measurement 
depths were chosen to coincide with the depth of dose maximum rounded to the 
nearest 5mm (the maximum depth increment available with the phantom in use). 
The optical densities, OD90 and ODio, at the same X axis locations on the film were 
recorded and, as discussed above, used as the basis for measuring the position of 
90% and 10% dose on films. Table 4.2 shows the mean distance from the field 
centre on the film to the OD90 level for the axis perpendicular to both the plane of 
rotation of the accelerator gantry and the beam central axis (corresponding to the 
collimator Y axis and labelled 0°) and for axes at 45® and 315® to the Y axis.
Also shown are distances to 90% dose calculated by TMS. Table 4.3 gives the 
same distances for 1 0 % dose.
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Energy
(MeV)
Depth (mm) X90 (mm) 
10x10 cm cutout
Xio (mm) 
10x10 cm cutout
6 10 45 58
9 15 46 58
12 20 46 58
16 15 47.5 55
20 15 47.5 56
Table 4.1. Diode measurements in a plane perpendicular to the field central axis for an electron 
beam defined by a 10 x 10 cm square cutout. Distances are those fom the field centre to the 90%
and 10% dose levels
Energy Depth Axis distance to 90% (film) Axis distance to 90% (TMS) 
(MeV) (mm) 10x10 cm cutout (mm) 10x10 cm cutout (mm)
00 450 315® 0® 45® 315
6 10 45 61 60 45 61 61
9 15 46.5 61 62 45 61 61
12 20 46.5 62 62.5 45 61 61
16 15 47 64.5 65 47 66 66
20 15 48 66 67 47.5 66 66
Table 4.2. Film measurements and TMS calculations of the 90% dose level for an electron beam 
defined by a 10 x 10 cm square cutout. Angles denote the angle o f a line projecting from the field 
centre to the edge o f the cutout in a plane perpendicular to the beam cetral axis .
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Energy Depth Axis distance to 10% (film) Axis distance to 10% (TMS)
(MeV) (mm) 10x10 cm cutout (mm) 10x10 cm cutout (mm)
00 450 3150 0® 45® 315
6 10 58 77 77.5 55 74 74
9 15 58.5 75 76 56 74 74
12 20 58.5 76.5 78 57 75 75
16 15 55.5 74 75 54 73 73
20 15 57 75 76 54 74 74
Table 4.3. Film measurements and TMS calculations o f the 10% dose level for an electron beam 
defined by a 10 x 10 cm square cutout. Angles denote the angle o f a line projecting fi'om the field 
centre to the edge of the cutout in a plane perpendicular to the beam cetral axis.
Figure 4.1 illustrates the data shown in tables 4.2 and 4.3 for 6  MeV and 20 MeV 
fields. The calculated 90% and 10% isodose profiles are shown together with 
those points at which 90% and 10% dose were measured.
Defining beam penumbra width on the y-axis as the distance between the 10% and 
90% isodose lines allows an estimation of this quantity to be made using the 0® 
data in tables 4.2 and 4.3. Penumbra widths are shown in figure 4.2.
4.3.2 Non linear film response
As an illustration of the non-linear nature of the film response near the cutout edge, 
a comparison of the recorded optical density at the beam central axis, ODca, with 
OD90 (the optical density at the position of 90% dose recorded by diode 
measurement) is shown for the 10 x 10 cm cutout in figure 4.3. Optical densities 
have been coiTccted for film background fogging.
6 8
Figure 4.1. Comparison o f TMS calculation (solid lines) and measured doses (crosses) for 
16 MeV (above) and 6 MeV (below) electron beams. Doses are displayed at the Dmax depth in a 
plane perpendicular to the beam central axis for a 10 x 10 cm field.
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Figure 4.2. Measured and calculated penumbra widths at the Dmax depth for a 10 x 10 cm electron
beam.
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Figure 4.3. Ratio o f the film optical density at the position o f 90% absorbed dose (OD90) to that on 
the central axis (10 x 10 cm cutout). Measurements made with electron beams defined by 10 x 10 
cm square ostalloy cutouts o f two different thicknesses: solid dots - 1 1mm thickness;
hollow dots - 2 2 mm.
A film responding linearly to absorbed dose would produce a value of exactly 0.9 
for the ratio of OD90 to central axis optical density. For the 1 0  x 10 cm cutout 
irradiated under standard conditions, the ratio shown in figure 4.3 lies consistently 
above 0.9. At electron energies up to and including 12 MeV the measured ratio
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lies just within the experimental uncertainty (+/- 2.5%) of 0.9, while at 16 and 20 
MeV it is outwith this, indicating a systematic difference in the measurements of 
film and diode. As discussed above, one possible cause of this is a non-linear film 
response to bremsstrahlung radiation produced during electron transmission 
through the cutout. To test this hypothesis, exposures at 16 and 20 MeV were 
repeated with a double thickness (2 2 mm) of ostalloy used to define the field edge. 
The reduced electron transmission resulting from the extra ostalloy should lead to 
reduced bremsstrahlung production. As illustrated in figure 4.3, the ratio of OD90 
to central axis optical density is indeed reduced to within the experimental 
uncertainty of 0.9 in this case.
4.3.3 Breast Boost Cutouts
There are six standard breast boost cutouts (BBl - BB6 ) in current clinical use at 
the Beatson Oncology Centre. For each cutout, exposures were made at all five 
available energies with the same monitor unit reading (and therefore total electron 
fluence ) as that applied to the 10 x 10 cm plain cutout. Measurements were made 
at the same (energy-dependent) depths used for the plain cutouts. For brevity, only 
those results relating to breast boost cutout number four (BB4) are shown. Figure
4.4 shows two exposures of BB4 at electron energies 6  and 20 MeV.
The suitability of using the previous value of O D 9 0  (i.e. the optical density at the 
position of 90% dose for a 10 x 10 cm field) for the breast boost cutouts was 
confirmed by diode measurements of relative absorbed dose in a water phantom 
made along the llQp degree axis of BB5. This axis intersects the region of 
maximum curvature on BB5 which is the most eccentric of the breast boost 
ellipses. The measured position of 90% dose was compared with that position on 
the film predicted to correspond to 90% dose using the value of O D 9 0  obtained 
previously. For both energies, the discrepancy between the diode and film 
predictions of the 90% dose position was less than 1mm. Existing values of O D 9 0  
were, therefore, used to predict 90% dose for subsequent film measurements of the 
breast boost cutouts.
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Figure 4.4. Film exposures of Breast Boost Cutout 4 exposed to 16 MeV (top) and 6 MeV electron 
beams. The projection at 100 cm SSD o f the major and minor axes o f the physical ostalloy
measures 10.2 cm x 6.5 cm.
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For each cutout, optical density measurements were made on 4 axes: the collimator 
X and Y axes and 2 further axes at 65^ and 115  ^to the Y axis in the case of breast 
boost cutout number 1 and at 60^ and 120^ to the Y axis for all other breast boost 
cutouts.
The axis orientations for BB2 - BB6  are shown schematically in figure 4.5. Using 
the known value of optical density corresponding to 90% dose (OD90), the distance 
along each axis at which the dose falls to 90% was now determined. In this way, 
eight points at which the absorbed dose falls to 90% of the maximum dose can be 
identified for each cutout at each energy.
Y
60
120
X
Figure 4.5. Schematic diagram showing axes for optical density measurements in breast boost 
cutouts (BB2 - BB6). “x” indicates a typical location for 90% dose.
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Figure 4.6. Projection of Breast Boost Cutout 4 in a plane perpendicular to the beam central axis for 16 MeV 
(above) and 6 MeV (below) electron beams. Within the cutout edge, two isodose lines are shown 
corresponding to 90% dose. Dotted isodose line - measured data, solid isodose line -  TMS calculation.
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Figure 4.6 depicts a projection of the inside ostalloy edge of BB4 as it appears at 
100cm SSD viewed with a diverging light field originating optically at the physical 
electron source. Also shown are the eight measured points corresponding to 90% 
of maximum dose and an interpolated 90% isodose line for electron energies 6  and 
16 MeV. Measured data corresponds to depths below the phantom surface of 
10mm and 15mm for 6  MeV and 16 MeV respectively. The TMS-generated 90% 
isodose line is also shown.
4.4 Discussion
This work has compared 2-dimensional dose profiles in the penumbra region of 
electron fields obtained by two methods: quantitative film dosimetry and the 
calculation algorithm of the HELAX TMS planning computer. Isodose profiles 
corresponding to 90% and 10% of central axis dose have been obtained for planes 
perpendicular to the beam central axis. Beam shaping apertures considered 
include 1 0 x 1 0  cm plain cutouts and a series of ellipses of varying eccentricity.
4.4.1. The effect of bremsstrahlung on film response.
The results clearly demonstrate the value of comparing film measurements in the 
penumbra region with data measured by diode. Evidence of a non-linear film 
response in the penumbra region is found in the comparison of OD90 (the film 
optical density at the position predicted by diode measurement to correspond to 
90% dose in the penumbra) with central axis optical density. The ratio of these 
measurements would always be 0.9 for a film responding linearly to absorbed dose. 
At each beam energy, however, the ratio is above 0.9 when calculated for the 10 x 
10 cm cutout. At beam energies of 16 and 20 MeV the discrepancy is larger than 
the estimated uncertainty of the film measurements, indicating a systematic 
difference in the film and diode measurements of relative dose in the penumbra 
region.
75
As discussed above, the likely cause for this increased film sensitivity in the 
penumbra is the contribution to absorbed dose made by low energy bremsstrahlung 
originating at the cutout and applicator. The transmission factor for 12 MeV 
electrons traversing 11mm of ostalloy is less than 5% [27]. For 20 MeV electrons 
the figure rises to approximately 10%. There are, therefore, far more electron 
interactions at the downstream edge of the cutout when this is used to define the 
higher energy beams. Increased production of low energy bremsstrahlung in this 
region of the cutout for high energy beams is also, therefore, more likely. This 
may well provide an explanation of the increase in non-linearity of the film 
response for 16 and 20 MeV beams. The non-linearity at 16 and 20 MeV is 
reduced if the thickness of ostalloy is increased to 22mm, for which the 
transmission factor is less than 5% for all beam energies.
4.4.2 Measurement and calculation uncertainties
Both the measured and calculated data are subject to factors which limit their 
accuracy. There are several uncertainties relating to the measured data: (1) the 
accuracy with which the film is positioned in relation to the densitometer, (2) the 
degree to which film sensitivity is reproducible, (3) densitometer resolution and (4) 
accelerator stability.
Films required to be scanned by the densitometer along axes of pre-defined angle 
with respect to the collimator y-axis. During optical density measurements, the 
maximum deviation from the correct scan orientation was estimated to be 0.5^ 
which, for a flat-sided cutout, corresponds to an axis displacement of +/- 0.2 mm. 
An error of this magnitude is sufficiently small to be disregarded.
The film used was Kodak XV2 verification film. For electron interactions, this 
film has a linear relation between optical density and absorbed dose for values of 
the latter used in this work [48]. As this work compares optical density at a pre­
determined location on one film exposed to a 10 x 10 cm field with that found on 
other films exposed separately, it is necessary to consider variations in film
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sensitivity to define measurement accuracy. It has been noted [68] that intra- and 
inter-film variations in sensitivity are likely to be no greater than +/- 1% and +/- 
1.5% respectively. The scanning densitometer used to read the films was capable 
of resolving single monitor unit increments in absorbed dose which, in this case, 
corresponds to approximately 2% of absorbed dose. It is thus reasonable to 
assume that random uncertainties in its sensitivity are no greater than +/- 1.0%. 
Accelerator stability is monitored daily and does not exceed +/- 1.0%.
Taken cumulatively these errors result in an uncertainty in dose measurements of 
approximately +/- 2.5%. In regions of steep dose gradient the resulting 
uncertainty in isodose position is no more than +/-0.5 mm. Adding this to the +/-
0.5 mm intrinsic spatial resolution of the densitometer results in a total uncertainty 
in penumbral isodose position of no more than +/- 1.0 mm.
The precision of the calculated data depends on (1) the resolution of the calculation 
grid (2.5 mm) and (2) the number and spacing of the pencil beams used by the 
calculation algorithm. Calculation accuracy depends on the detail with which 
electron transport and scatter processes within and upstream of the phantom are 
modelled. Of particular relevance for cutout penumbras at shallow depth is the 
modelling of electron scatter in the applicator and at the edges of the cutout.
These phenomena are machine-specific and therefore it is important to recognise 
that errors in absorbed dose calculations due to limitations in the algorithm are also 
machine-specific.
4.4.3 Discrepancies between the measured and calculated data
For the majority of cutout geometries there is good agreement between TMS and 
the measured data in the position of the 90% isodose line. The displacement of 
the calculated from the measured 90% line showed deviations of no more than 1.0 
mm for the elliptical cutouts at all energies between 6 and 20 MeV. For the 10 x 
10 cm plain cutout, positional deviations in the 90% isodose line were 1.5 mm or 
less where the square side of the cutout intersects the X and Y axes. The same
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maximum positional deviation was observed at the right-angled comers of the 
cutout. Calculated positions of the 90% isodose line, therefore, lay within the 
range of error of the measured data for all cutout geometries.
Deviations in the 10% isodose line for the 10x10 cm square cutout were slightly 
higher for all energies. TMS underestimates the displacement of the 10% isodose 
line from the beam central axis on all the profile axes considered at all energies. 
The mean discrepancy is 2mm and is as large as 3.5mm for the 315^ corner of the 
cutout with a 6 MeV beam energy. As with the 90% isodose line, calculation 
accuracy shows no significant dependence either on beam energy or on location in 
the cutout.
ICRU report 42 [23] states that a computed dose distribution may be considered 
accurate if the calculated position of an isodose line lies within 2 mm of its actual 
position. The inaccuracy in the calculated position of the 10% line is, therefore, 
notable. Blomquist [19] reported similar findings and offered an explanation for 
the discrepancy by referring to the contribution to dose made by scattered electrons 
from the applicator and cutout. The influence of this scatter on beam penumbra 
has been previously described [29] and is often modelled using a virtual SSD 
which varies with beam size and energy. TMS uses a combination of measured 
full width at half maximum data and a r.m.s. scattering angle supplied by the user 
at commissioning to define penumbra postion and width respectively. There is no 
explicit modelling of applicator and cutout scatter. The user-supplied parameters 
are optimised for the positions of the 90% and 50% isodose lines, and so the 
calculated position of the 10% isodose line is prone to greater error.
As well as scattered electrons, it has been suggested [78] that leakage of primary 
radiation through the applicator walls contributes significantly to absorbed dose at 
depths up to the depth of dose maximum in the extreme periphery of the beam.
This leakage is not modelled by TMS. Underestimation of the displacement of the 
10% isodose line from the beam central axis (as found here) is consistent with the 
algorithm’s failure to include the contribution made by leakage radiation.
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The measured and calculated data show a similar energy dependence in the 
distance from the cutout edge to the 90% isodose for the 10 xlO cm and elliptical 
cutouts. Energy dependence is also apparent in the position of the 10% isodose 
line and in the distance between the 10% and 90% isodose lines (the penumbra 
width). Measured penumbra width for the 10 cm cutout varies from 13 mm for 
the 6MeV beam to 8.5 mm for the 20 MeV beam. Calculated penumbra width 
varies from 10 mm (6 MeV) to 6.5 mm (20 MeV). The discrepancy between 
measured and calculated penumbra width is due almost entirely to the discrepancy 
in the 10% isodose line. Both the measured and calculated data show penumbra 
width remaining approximately constant for beam energies between 6 and 12 MeV 
(inclusive). There is then an abrupt decrease in width at 16 MeV, the 20 MeV 
field maintaining this reduced value.
The energy dependence of beam penumbra width has its origins in multiple 
scattering theory [31]. As discussed above, electron scatter prior to the intersection 
with the phantom is characterised by means of a r.m.s. scattering angle. This 
parameter then determines the spread of the pencil beams used by TMS to assess 
dose at depth in the penumbra. The calculations, though giving rise to some 
inaccuracy in the 10% isodose line, have adequately reproduced the pattern of 
energy dependence in beam penumbra width.
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Appendix A4.1 
Dose response of the measurement Him
Figure A4.1 (below) illustrates the sensitivity and reproducibility of the 
measurements made with Kodak XV2 verification film. Optical density at the 
field centre of a 60 x 60 mm cutout was recorded for a series of 6 MeV fields. 
Applied dose was increased by 2 cGy for each successive field.
Also shown is the best straight line fit for the measured data 
Slope = 2.28 +/- 0.05 cGy/vertical scale division.
Intercept = 35.2 +/- 2 vertical scale divisions.
Film Sensitivity
155
Optical
Density
(arbitary
units)
40 41 42 43 44 45 46 47 48 49 50
Dose (cGy)
Figure A4.1. Variation of optical density with applied monitor units for Kodak XV2 verification 
film. Film was exposed to a 6 MeV 6 x 6 cm field in a TEMEX phantom.
80
CHAPTERS 
CALCULATION OF ABSOLUTE DOSE
5.1 Introduction
An adequate description of a radiotherapy treatment usually requires the treatment 
plan to contain a description of the relative dose distribution. More 
fundamentally, the plan must always contain a statement relating the measurement 
of radiation by the treatment unit’s ionisation chamber (in monitor units) to the 
absolute dose (in cGy) at a specified point in the patient. For most single field 
treatments, whether given with electrons or photons, this point is chosen as the 
depth of dose maximum on the beam central axis (the Dmax point). This point 
usually coincides with the centre of the treatment area and avoids regions of steep 
dose gradient. Confirmation of the suitability of this point for dose prescription is 
provided by the ICRU in report number 50 [67].
Most treatment planning systems allow the user to move the dose prescription 
point away from the Dmax point if necessary, and hence require the point to be 
chosen explicitly. It is then referred to as the normalisation point. For a single 
field treatment, the number of monitor units required to give a dose of 100 cGy to 
the normalisation point is referred to as the output of the field. Thus, in any given 
situation in which an electron field is incident on a patient or phantom, 
specification of the output (from the treatment plan) and the intended prescription 
dose (from the clinician) is sufficient to calculate the required monitor units.
Traditionally, treatment planning systems have calculated output by referring to a 
look-up table of measured values [79,80]. When the field being modelled falls 
within the scope of the look-up table, this method has the advantage of providing 
an output value with a certain known accuracy. The disadvantage of this system is 
that it requires the user to perform many time-consuming dosimetry measurements. 
An alternative approach is to supply the planning system with a limited set of 
reference measurements and use a beam modelling algorithm to calculate the 
output for a given field in relation to the reference measurements. As well as
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requiring fewer measurements, this method has the flexibility to calculate outputs 
for non-standard conditions such as irregularly shaped fields.
The two treatment planning systems under consideration here adopt differing 
approaches to the calculation of output. The Cadplan system depends largely on 
measurements while Helax TMS makes use of both measured and calculated data. 
The formalism behind this latter, more complex, method may be applied to both 
electron and photon fields, and has been discussed at length [81,82]. An 
assessment of the accuracy of the Cadplan and TMS monitor unit calculations 
provides a comparison of two different methodologies. For Cadplan the accuracy 
of the final monitor unit value depends on the accuracy of the data in the look-up 
table and the way in which the system arrives at a choice of look-up data. The 
accuracy of the TMS monitor unit calculation depends on the completeness of the 
theoretical formalism in use, as well as the accuracy of the initial measurement set 
incorporated therein.
In this work, output values predicted by the treatment planning systems were 
assessed by comparison with measurements made with an ion chamber in a water 
phantom. The inclusion of more complex phantom geometries for certain 
comparisons required associated output measurements to be made with 
thermoluminescent dosimeters. These were calibrated by comparison with ion 
chamber measurements. While introducing an additional element of uncertainty, 
the use of TLD in absolute dose determination is well-established [31,83].
5.2 Materials and Methods
5.2.1 Field set-up and phantom geometry
The accuracy of monitor unit calculations performed by the treatment planning 
computers was assessed for a variety of beam shapes, phantom geometries and 
source-skin distances (SSDs). Dose calculations were performed using Helax 
TMS v4.1A and Varian Cadplan v3.1.1. Exposures were made with a Varian 
2100C linear accelerator (Varian Associates, as before) at beam energies in the
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range 6 to 20 MeV. Table 1 provides a summary of the four basic experiments 
carried out. Experiments 1 and 2 examined the variation in output with SSD and 
field cutout size respectively. Experiments 3 and 4 reproduced two situations first 
discussed in chapter 2: a beam incident on a plane phantom at an angle of 30°, and 
a beam incident normally on a phantom containing a tapered bolus edge. The four 
experiments are discussed in detail below.
1. Extended SSD. As discussed in chapter 3, electron treatments of the head and 
neck often require the use of SSDs greater than 100 cm in order to provide 
clearance between the patient’s shoulder and the treatment applicator. The 
accuracy of monitor unit calculations for 10 x 10 cm and 5 x 5 cm fields was 
assessed for the SSD range: 100 cm -  120 cm. SSDs greater than 110 cm are 
rarely used in clinical practice, but an examination of the output calculation at 
SSDs of up to 120 cm provided useful information on trends in the relation 
between output and SSD.
Five beam energies in the range 6 - 2 0  MeV were considered for the 10 x 10 cm 
field. For the 5 x 5  cm field, only those beam energies at the upper and lower 
limits of the range in common clinical use were considered i.e. 6 MeV and 16 
MeV. Measurements were made in a mini water phantom supplied by QADOS 
Ltd. This device can be adapted to house a variety of parallel plate chambers for 
electron dosimetry. The internal dimensions of 29.5 x 35 x 29.5 cm provide a 
large enough margin to ensure equilibrium of scatter into the central axis for the 
field sizes and beam energies considered in this work [34].
Both planning systems use the concept of a virtual source to model the effects that 
scatter in the machine head have on the output at extended SSD. The virtual 
source concept is used widely in electron dosimetry, and has been discussed at 
length in the literature [37,47]. Scattering events in the applicator cause an 
increase in the mean scattering angle of electrons. This, in turn, causes the beam 
to spread out more rapidly beyond the applicator than a simple inverse square 
expansion would indicate. The beam thus appears to originate from a virtual 
source situated downstream of the physical source. A reduction in beam fluence
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results from the increased beam area beyond the applicator, and hence the required 
output is greater than would be required for a beam exhibiting inverse square 
behaviour. The distance from the physical to the virtual source position, Zyinuai, is 
that distance which allows the output at extended SSD, O P s s d , to be described by 
an inverse square law of the form
DP SSD — DP standard * (SSD — Zyirtual Dmax) / (SSDgtandard ~ Zyjrtual Dmax) (1)
where DPstandard is the output at the standard source skin distance, SSDstandard- By 
substituting a measured or calculated value of D P ssd in equation (1 ) ,  and then re­
arranging the terms, the implied location of the virtual source can be calculated. 
This method was employed to calculate the value of Zyjrtuai implied by both the 
measured and computed outputs.
2. Field size. The use of ostalloy cutouts to define field sizes smaller than the 
plain applicator was discussed in chapter 4. A 10 x 10 cm applicator was fitted 
with a series of field-defining cutouts of successively smaller square side. The 
smallest field aperture considered was 3 x 3  cm. Fields smaller than this do not 
achieve scatter equilibrium on the central axis and are rarely used clinically due to 
the resulting unfavourable depth dose distribution.
3. Oblique incidence. The relative isodose distribution for this field arrangement 
was considered in chapter 2. To complement this, the experimental set-up was 
reproduced, and an assessment made of the monitor unit calculation. As before, 
an obliquely incident field intersects a WTe solid water phantom at an angle of 30° 
to the vertical, at a SSD of 102 cm. Comparison of measured and calculated 
output was performed at a point 2.7 cm along the beam central axis. This point 
was chosen to correspond with the Dmax point for 12 MeV electrons. It was used 
as the normalisation point for the relative dose distribution shown in figures 2.8 
and 2.9 on pages 17 and 18.
4. Bolus Edge. As with the oblique incidence experiment, the relative dose 
distribution for the bolus phantom was considered in chapter 2. The Bolus
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phantom consists of a WTe solid water foundation overlaid with a PMMA block 
with an edge tapering at 45° (see figure 2.1 (4), page 13). To coincide with a 
region of reasonable dose homogeneity, the relative dose distribution was 
normalised to a point 7.0 cm distant from the beam central axis at a depth of 2.7 
cm. This point was chosen for the assessment of output.
5.2.2 Measurement devices
Output measurements for experiments 1 and 2 were made with an ion chamber in a 
water phantom. This is universally recognised as the most accurate method of 
measuring absorbed dose per monitor unit [34,84,85]. For experiment 1, and for 
field sizes greater than 4 cm x 4 cm in experiment 2, measurements were made 
with a Roos 34001 parallel plate chamber (Gothic Crellon Ltd, 3 The Business 
Centre, Molly Millars Lane, Wokingham RGl 1 2EY). The chamber was 
interfaced to a NE 2570 / 1 electrometer (NE Technology Ltd, Bath Road, 
Beenham, Reading, Berkshire RG7 5PR). The Roos chamber has a relatively 
large cross-section with a collecting electrode diameter of 16 mm. For field sizes 
of 4 cm X 4 cm or less, measurements were made with the smaller NACP chamber 
(QADOS Ltd, as before). This device has a collecting electrode diameter of 10 
mm and avoids the possibility of the field penumbra infringing on the chamber’s
Experiment SSD Energy Field Measurement Phantom Measurement
(cm) (MeV) Size
(cm)
Point Material Technique
1. Extended 1 0 0 -1 2 0 6 - 2 0 lO x 10, Water Ion
SSD 5 x 5 chamber
2. Field size. 100 6, 16 Variable Oinax Water Ion
chamber
3. Oblique 102 12 19x 19 Dmax distance WTe solid TLD
incidence along central 
axis
water
4. 45” bolus 100 12 19x 19 7 cm lateral, WTe solid TLD
edge depth = Dmax water
Table 5.1. Summary o f experiments undertaken to compare monitor units measured in four 
situations with those calculated by the Helax TMS and Cadplan planning computers.
85
active volume.
Measurements with the Roos chamber were carried out according to the IPEMB 
1996 code of practice [8], currently recommended for electron dosimetry in the 
UK. Appendix A5.1 contains an example of the calculations required to convert 
measurements made with the Roos chamber from ionisation to absorbed dose. A 
description of the environmental and chamber related correction factors involved in 
the calculation is also given.
The NACP chamber was calibrated against the Roos chamber. This was achieved 
by comparing ionisation recorded by the NACP chamber with absorbed dose 
measured by the Roos chamber. Immediately prior to its use in assessing the 3 x 3 
cm and 4 x 4  cm fields, the NACP chamber was used to record ionisation at the 
Dmax point for a 10 x 10 cm field in the water phantom. Both 6 and 16 MeV fields 
were considered. The chamber was then replaced with the Roos model, and this 
chamber used to measure absorbed dose for the same field size, energies and 
monitor units. The ratio of absorbed dose (Roos) to ionisation (NACP) was then 
calculated. Subsequent measurements of ionisation made with the NACP chamber 
for small fields were converted to absorbed dose by applying a calibration factor 
equal to this ratio.
Due the to extra calibration step, the measurements with the NACP chamber were 
not made in strict accordance with the code of practice. Any errors introduced by 
this extra step are likely to be very small, however, since the long term 
reproducibility of both chambers is better than 0.5% [34].
TLDs were chosen to assess output for the oblique incidence and bolus phantoms 
because of their small size. TLD measurements were preferable to those of an ion 
because experiments 3 and 4 require measurements to be made in regions 
containing a dose gradient. In the case of the obliquely incident field, an ion 
chamber measurement would require the entry face of the chamber to be situated at 
an angle of 30° to the horizontal to facilitate normal incidence of the beam central 
axis. Consequently, one side of the chamber would be closer to the phantom
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surface, resulting in a dose gradient across the chamber. The bolus phantom 
contains steep dose gradients due to the scattering effect of the bolus edge. Output 
measurements were made in the most homogeneous dose region but the relatively 
large surface area of parallel plate chambers would still result in an appreciable 
dose gradient across the chamber, as an examination of figure 2.12 shows. The 
detector requires a small cross-sectional area to reduce errors associated with 
averaging a changing dose over the detector volume. Using TLD is, therefore, 
preferable to ion chamber dosimetry.
TLDs were of the lithium fluoride square chip variety and were described in detail 
in chapter 2. Prior to experiments 3 and 4, a batch of 20 TLDs was selected and 
calibrated against the Roos chamber. To achieve this, each of the TLDs was first 
assigned a relative sensitivity according to the method described in appendix A2.1. 
The TLDs were then annealed using a temperature cycle recommended by the 
manufacturer (1 hour at 400°C followed by 14 hours at 80°C). Ten TLDs were 
exposed to an electron beam under reference conditions (10 x 10 field, 100 cm 
SSD). This exposure was made with a set number of monitor units, with TLDs 
situated at the depth of dose maximum in a WTe solid water phantom. A beam 
energy of 12 MeV was selected since this was the energy at which subsequent TLD 
output measurements were made. The solid water was then replaced with the 
water tank, and the Roos chamber used to measure the absorbed dose delivered 
under the same reference conditions. A batch calibration factor was then assigned 
to all 20 TLDs. The remaining 10 TLDs were then divided into two batches of 5 
and used to measure output for the obliquely incident and bolus fields.
5.3 Results
5.3.1 Experiment 1. Variation of output with SSD
Figures 5.1 -  5.4 show the variation in output with SSD for field sizes of 10x10 
cm and 5 x 5 cm at beam energies of 6 and 16 MeV. Measured values are 
compared to those calculated by the two treatment planning systems. Both 
planning systems are constrained to yield an output of 100 MU / lOOcGy at all
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Figure 5.1. Variation o f output with SSD for a 6 MeV, 10x10 cm electron field (experiment 1). 
Measurements were made with an ion chamber in a water phantom. Calculations performed by
Helax TMS and Varian Cadplan.
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Figure 5.2. Variation o f  output with SSD for a 16 MeV, 10x10 cm electron field (experiment 1).
Measurements were made with an ion chamber in a water phantom. Calculations performed by
Helax TMS and Varian Cadplan.
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Figure 5.3. Variation o f output with SSD for a 6 MeV, 5 x 5 cm electron field (experiment 1). 
Measurements were made with an ion chamber in a water phantom. Calculations performed by
Helax TMS and Varian Cadplan.
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Figure 5.4. Variation o f  output with SSD for a 16 MeV, 5 x 5 cm electron field (experiment 1).
Measurements were made with an ion chamber in a water phantom. Calculations performed by
Helax TMS and Varian Cadplan.
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beam energies for a 10 x 10 cm field size at 100 cm SSD. For the measured 
outputs, there is a systematic difference between the IPEMB 1996 dosimetry 
protocol, and the earlier protocol in use at the time the linear accelerator used in 
this work was commissioned. The impact of this systematic difference is 
discussed in section 5.4. In order to aid clarity in comparing the trends in the 
relation between output and SSD, the effects of this difference were removed by 
normalising the measured outputs to 100 MU/ 100 cGy for a 10 x 10 cm field at 
100 cm SSD for both 6 and 16 MeV energies.
The IPEMB quote an estimated uncertainty of 2.5% (1 standard deviation) in the 
measurement of absolute dose [34]. In assessing the uncertainty of measured 
outputs in a comparison with calculations, this uncertainty is not relevant since the 
planning computers merely reproduce the measured output at 100 cm SSD. The 
magnitude of uncertainty in relative output measurements at extended SSD, is 
therefore related only to any additional uncertainties arising from taking these 
further measurements. Reproducibility in measurements of a single dose value 
were estimated at 0.1% (1 s.d.) for this work. The IPEMB quote an inter­
measurement uncertainty of 0.8% due to set-up errors and limitations in the 
instrument readout. A pragmatic approach is to quote the error in relative dose 
measurements made with the Roos chamber in this work as the larger of the these 
two figures i.e. +/- 0.8%.
Of the four fields shown in figures 5.1 -  5.4, the largest discrepancies between 
measured and calculated data arise for the 5 x 5 cm, 6 MeV field. The 
measurements demonstrate a significantly steeper gradient in the relation between 
output and SSD for this field. This steeper gradient has not been reproduced 
accurately by either planning system. Table 5.2 shows the discrepancies between 
the measured and calculated outputs at 110 cm and 120 cm SSD for beam energies 
6 and 16 MeV at the 10x10 cm field size. The table also shows discrepancies at 
the 5 X 5 cm field size.
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SSD (cm) 110
Field size (cm) lOx 10 5 x 5 lOx 10 5 x 5
Energy (MeV) 6 16 6 16 6 16 6 16
TMS (%) -0.9 + 0.2 - 5.5 -2.2 -1.5 +0.1 -11.2 -3.8
Cadplan (%) -3.2 -3.3 + 7.5 -2.8 -0.3 -6.4 + 13.6 -6.2
120
Table 5.2 Discrepancies between calculated and measured output for various electron fields at 110 
cm and 120cm SSD. Percentage discrepancies are positive where the planning system’s 
calculation exceeds the measurement.
Figures 5.1 to 5.4 and table 5.2 demonstrate increasing errors in the calculated 
output as the SSD increases. To investigate the cause of this trend, the relation 
between output and SSD used by the planning computers was assessed by 
calculating the virtual SSD implied by their output values. This was 
done by re-arranging equation 1 and finding the mean value of Zvinuai over the 
SSD range 105 -  120 cm at a each combination of field size and energy. The 
results are shown in figures 5.5 and 5.6. The virtual SSD implied by the measured 
output / SSD relation is also shown. In addition to beam energies 6 and 16 MeV, 
figure 5.5 (for the 10 x 10 cm field size) includes data for beam energies 9, 12 and 
20 MeV.
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Figure 5.5. Virtual SSDs values implied by the variation of output with SSD in the measured and 
calculated data for a 10 x 10 cm electron field. Calculations performed according to equation I.
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Figure 5.6. Virtual SSDs values implied by the variation of output with SSD in the measured and 
calculated data for a 5 x 5 cm electron field. Calculations performed according to equation 1.
Figure 5.5 reveals a serious flaw in the calculation performed by Cadplan for the 
10 X 10 cm field. Virtual SSDs identical to the measured values were supplied to 
this system prior to the assessment. These should be reflected in the calculated 
virtual SSDs but are not. Furthermore, the values of virtual SSD actually apparent 
in the calculated data are greater than 100 cm for beam energies 9 - 2 0  MeV.
Thus, calculated electron fluence beyond the applicator falls off less rapidly with 
SSD than an inverse square law based on the physical source position would 
dictate. Physically, this is unrealistic.
Measured values of virtual SSD are considerably smaller for the 5 x 5 cm field than 
for the 10 X 10 cm field. Furthermore, at the smaller field size, figure 5.6 reveals 
that the measured virtual SSD shows a clear energy dependence. It is significantly 
reduced at the lower beam energy. The explanation for this lies in the increased 
role of scatter from the cutout to the Dmax point on the central axis at the standard 
SSD for the small, low energy field. This scatter contribution diminishes very 
rapidly at extended SSD and causes this field to exhibit a very small virtual SSD.
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Figure 5.7. Variation in output with field size for a 6 MeV electron field at 100 cm SSD. 
Measured data was collected with an ion chamber in a water phantom, and has error bars displayed.
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Figure 5.9. Measured and calculated outputs for a 12 MeV, 10 x 10 cm electron field incident on a 
plain phantom at an angle of 30° to the vertical. Output values are relative to the same field with
normal incidence.
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Figure 5.10. Measured and calculated outputs for a 12 MeV, 10 x 10 cm electron field incident on 
a surface containing a tapered bolus edge. Output values are relative to the same field incident on a
plain phantom.
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5.3.2 Experiment 2. Variation of output with field size
The relation between output and field size is shown in figures 5.7 and 5.8. A 10 x
10 cm applicator was fitted with successively smaller ostalloy cutouts of thickness
11 mm to produce the required field size variation. Beam energies of 6 and 16 
MeV were considered. The lower beam energy was not modelled aecurately by 
the TMS algorithm at field sizes smaller than 5 x 5  cm. Loss of side scatter 
equilibrium for these fields results in a sharp increase in measured output, typically 
of the order of 10% on reducing field size from 5 x 5 cm to 3 x 3 cm. The 
theoretical extrapolation from a plain 10 x 10 cm field size used by TMS has failed 
to model this loss of side seatter. Reliance on a stored table of output versus field 
size, however, allows Cadplan to reproduce the effect accurately.
5.3.3 Experiments 3 and 4. Oblique incidence and bolus fields
Outputs for the obliquely incident and tapered bolus fields are shown in figures 9 
and 10. The beam energy is 12 MeV in eaeh case. Outputs were measured with 
TLDs. The estimated uncertainty in measured output was +/- 2.2%. This figure 
is justified in section 5.4 (Discussion).
The output for the 30° oblique field calculated by TMS exceeds the measured value 
by 3.4%, while Cadplan proves accurate to within 1%. Both planning systems 
calculate higher outputs for the bolus phantom than those indicated by the 
measurements: TMS by 3.9% and Cadplan by 2.7%. A known systematic error in 
the value of the standard output supplied to the planning systems at the 
commissioning stage contributes to the size of these discrepaneies. This is 
discussed in section 5.4.4. The impaet on overall treatment accuracy of the errors 
in output value can only be assessed properly when considered with the respective 
isodose distributions shown in chapter 2.
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5.4 Discussion
The aim of this work was to assess the accuracy of two treatment planning systems, 
Helax TMS v4.1 A and Varian Cadplan v3.1.1, in the calculation of electron output. 
Experiments were performed to test the calculation accuracy under conditions 
removed from the standard reference conditions, where output is pre-defined in the 
planning systems. Four such situations were considered; extended SSD; reduced 
field size; oblique incidence; and incidence on a tapered bolus edge.
5.4.1 Measurement and Calculation Uncertainties
The aceuracy of output calculations made by the treatment planning systems was 
assessed by comparison with ion chamber and TLD measurements. Ion chamber 
measurements were made in accordance with the IPEMB 1996 code of practice. 
Chamber measurements were used to assess output directly, and as a means of 
calibrating TLD devices. The reproducibility of measurements made with the 
Roos chamber in this work was approximately 0.1%, though an inter-measurement 
uncertainty of +/- 0.8% has been quoted in accordance with IPEMB 
recommendations [34].
This random uncertainty is small in comparison with the systematic discrepancies 
whieh can be expeeted in a comparison with planning computer calculations. One 
such systematic discrepancy is introduced purely because of the choice of 
dosimetry protocol. The original output measurements on which both planning 
systems base their calculations were made in accordance with the HP A (1985) 
code of practice [86]. It has been noted that output measurements made in 
accordance with this protocol may differ from those made under the current 
IPEMB protocol by as much as 1.5 % [87]. In fact, for a 12 MeV 10 x 10 cm 
field, measurements made in this work revealed a 1.2% decrease in measured 
output (in MU/lOOcGy) on moving from the HP A to IPEMB protocols. This 
effect may be ignored in the comparisons involving SSD and field size variations. 
Here, measured and calculated outputs were normalised to 100% for a 10 x 10 cm,
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100 cm SSD field to aid clarity. The difference will, however, contribute to any 
discrepancy between measured and calculated output for the oblique incidence and 
tapered bolus experiments, where absolute output values were considered.
There are many other factors which could introduce systematic errors to the 
calculated outputs. The relation between beam fluence at the accelerator monitor 
chamber and absorbed dose at depth in a patient or phantom is a complex one. The 
physical interactions undergone by electrons which influence this relation may be 
divided into two broad categories: those occurring in the machine head, and those 
occurring in the phantom. Machine head interactions include scatter (both 
forwards to the phantom and back to the chamber) from metallic objects such as 
the secondary collimators, applicator and cutout, and modifications to the beam 
fluence profile caused by the scattering foil. Phantom interactions consist largely 
of multiple small angle scattering events with atomic electrons in the phantom 
material. Thus a change in, for example, applicator size, or the addition of bolus 
to the phantom surface, could both alter the electron fluence at a given point within 
the phantom. To calculate the monitor units required to give a particular dose in 
the phantom with acceptable accuracy, a planning computer must either model 
these effects explicitly or screen them out by relying on measured data.
5.4.2 Experiment 1. Variation of output with SSD
Experiment 1 considered the variation in output with SSD. At SSDs beyond the 
standard distance of 100 cm, the beam area expands, resulting in reduced electron 
fluence at the central axis. There is a eonsequent increase in output which, in the 
case of photon fields, can be calculated with great accuracy by applying a simple 
inverse square correction i.e. the beam fluence varies as the inverse of the square of 
the source to phantom distance. The output, therefore, varies as the square of the 
source to phantom distance. For electron fields, scatter events in the maehine head 
cause the beam area to expand more rapidly, causing this simple inverse square 
relation to breakdown. Moreover, the degree to which scatter affects the beam 
area beyond the standard SSD is dependent on beam energy and applicator size
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[48,88]. This work has examined the relation between output and SSD for beam 
energies in the range 6 to 20 MeV at field sizes of 10 x 10 cm and 5 x 5  cm.
Output values at 100 cm SSD are supplied to both TMS and Cadplan at the 
commissioning stage. Data is supplied for all available beam energies at each of 
the standard square applicator sizes (6, 10, 15, 20 and 25 cm). For Cadplan, data 
is also supplied at intermediate field sizes and for sizes below 6 x 6  cm. The two 
planning systems use different methodologies to extrapolate this basic data to 
calculate output at extended SSDs. Cadplan adopts a three stage process. Firstly, 
any effects that the algorithm employed by Cadplan to calculate phantom scatter 
has on absorbed dose at the D^ax depth at reduced field size are reversed by 
applieation of a field size factor from a stored data table. Secondly, the output at 
100 cm SSD for the appropriate field size is found from a second stored data table. 
Finally, the treatment field output is calculated by applying an inverse square 
correction using a virtual SSD found by referring to a third data table. Values for 
the first table are inferred by the user at the commissioning stage using a protocol 
provided by the manufacturers. The second and third tables use measured data. 
Values of virtual SSD measured in this work were used in the third data table.
TMS attempts to model the electron fluence at extended SSD by expanding the 
beam such that the centre of the penumbra is consistent with a set of full width at 
half maximum (FWHM) measurements. These are made at the standard and 
extended SSD at the commissioning stage. For a given field at extended SSD, this 
allows the surface fluence on the beam central axis relative to a reference beam to 
be calculated. Phantom scatter is then added explicitly in order to calculate the 
fluence at the normalisation point, and the output calculated.
For the 10 X  10 cm field size, the caleulation of output by Cadplan is not accurate. 
The calculated output often falls outwith the uncertainty range in the 
measurements, as figures 5.1 and 5.2 show. The calculation becomes 
progressively less accurate as the SSD is increased. Table 5.2 shows, for example, 
that output for the 16 MeV field is underestimated by 3.3% at 110 cm SSD, and by 
6.4% at 120 cm SSD. Figure 5.5, which shows the values of virtual SSD implied
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by the measured and calculated outputs, illustrates the reason for the increased 
error in calculated output at higher SSDs. For all the beam energies, Cadplan fails 
to reproduce the values of virtual SSD in its own tables. The result is a divergence 
from measurements in the output / SSD relation giving increasing errors in the 
calculated outputs as the SSD is increased. Varian has been approached about this 
but has yet to offer an explanation for this failure.
Cadplan shows a similar failure to reproduce the correct values of virtual SSD for 
the 5 x 5  cm field. The most serious consequence of this arises for the 6 MeV 
field, which has the smallest of all measured virtual SSDs, and therefore, an output 
which increases very rapidly with SSD. In contrast to thelO x 10 cm field, 
Cadplan overestimates the output. The error increases with SSD to reach 13.6% at 
120 cm.
There are no known flaws in the calculation algorithm which would explain 
Cadplan’s failure to reproduce the relation between output and SSD. While this 
situation persists, the magnitude of the errors precludes the clinical use of Cadplan 
for output calculations at extended SSD.
The TMS calculation of output proved accurate to within 1% at all SSDs for the 10 
X 10 cm, 16 MeV field. Accuracy at 6 MeV for this field size was to within 1.5%. 
As with Cadplan, the smaller 5 x 5 cm field is not modelled as accurately. 
Calculated outputs are consistently less than the measured values. At 110 cm, the 
discrepancies are 5.5% and 2.2% for 6 and 16 MeV fields respectively. The 
corresponding figures at 120 cm SSD are 11.2% and 3.8%.
Inadequacies in the TMS algorithm cause the large discrepancies at 6 MeV. The 
FWHM method may be accurate in describing field edge position but there is no 
reason to believe it provides an accurate indieation of relative electron fluence on 
the central axis, nor, therefore, of the beam output. Furthermore, while phantom 
scatter is explicitly modelled, scatter from the applicator and cutout are not. Any 
contribution these make to the beam fluence on entry to the phantom is, therefore.
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ignored. As with Cadplan, the use of TMS to calculate outputs at extended SSD 
is not advisable.
5.4.3 Experiment 2. Variation of output with field size
Experiment 2 examined the relation between field size and output. Beam energies 
of 6 and 16 MeV were considered for a 100 cm SSD field incident normally on a 
water phantom. A 10 x 10 cm field defined by a plain applicator was reduced in 
size by introducing successively smaller square ostalloy cutouts. The addition of 
these field-defining apertures was modelled on the planning systems by defining 
aperture blocks in the beam’s eye view image.
Both planning systems use a ray-tracing method to determine the position of the 
blocks in relation to any given point in the phantom, and to the physical electron 
source. Cadplan then uses this information to calculate an equivalent field size 
which is used to look up an output value from a stored data table. For the 10 x 10 
cm applicator, this table contains measured output values for square fields 
measuring from 2 x 2  cm upwards. The stored output values agree with those 
measured in this work to within 0.5%. In contrast to this, TMS attempts to 
integrate scatter contributions to dose at the normalisation point from pencil beams 
in the open field. The resulting dose is then compared to that which would have 
been calculated for a 10 x 10 cm reference field (for which the output is known), 
and the monitor units scaled accordingly.
As would be expected of a system which simply refers to a look-up table of output 
versus field size, Cadplan predicts the former with acceptable accuracy for all field 
sizes at both energies. Calculated and measured values agree to within the 
measurement uncertainty of 0.8%. This provides confirmation that the field 
defining apertures are being interpreted correctly in a geometrical sense, and an 
appropriate equivalent field size ealculated.
At 16 MeV, the TMS output calculation proves accurate to within 1% for all field 
sizes. This level of accuracy is not, however, maintained at 6 MeV. Here the
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calculated and measured outputs agree to within 1% for field sizes of 5 x 5 cm and 
above, but for the 4 x 4  cm and 3 x 3  cm fields, there are discrepancies of 1.8% and 
8.4% respectively. There is an obvious failure by TMS to reproduce the sharp 
increase in output measured for the smallest field sizes. Physically, the increase in 
output is caused by loss of side scatter equilibrium on the beam central axis.
While this provides a diffieult test, the explicit modelling of phantom scatter 
carried out by TMS should reproduce the effect adequately. Helax could not offer 
an explanation for this failure, but indicated that they expect future software 
releases to be more accurate.
5.4.4 Experiments 3 and 4. Oblique incidence and bolus fields
Experiments 3 and 4 examined output calculations for two specific set-up 
geometries. Firstly, a field incident obliquely on a plain WTe electron solid water 
phantom, and secondly, a field normally incident on the same phantom with a 
tapering PMMA block mounted on the beam entry surface to simulate a bolus 
edge.
Since the obliquely incident field measures 10x10 cm, and has a SSD of 102 cm, 
the beam fluence profile on entry to the phantom is close to that of a standard 10 x 
10 cm beam. To a large extent, therefore, the experiment tests the ability of each 
planning computer to compute phantom scatter from the oblique field in relation to 
a normally incident field. Similarly, accurate computation of the phantom scatter 
imposed on a standard 19x19 cm field by the presence of the bolus is crucial in 
this simulation.
It has been reported that oblique incidence tends to increase dose at the Dmax point 
[38]. This effect has not been reproduced in the these measurements. As 
discussed above, a 1.2% difference between calculated and measured outputs was 
expected to occur due to a systematic difference between dosimetry measurements 
made in this work and those used to supply data to the planning computers. 
Calculated outputs from both planning computers were expected to be 1.2 % higher 
than the measured values. After subtracting this amount from the calculated
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values, Cadplan calculates output for the oblique field to within 0.5% of the 
measured value while TMS overestimates this output by 2.2%. As discussed in 
chapter 2, the uncertainty in TLD measurements of relative dose is approximately 
+/- 2.0%. To find the uncertainty in a TLD measurement of absolute dose, this 
figure must be added, in quadrature, with the 0.8% uncertainty in ion chamber 
measurements used to calibrate the TLDs. This addition yields an uncertainty in 
TLD output measurements of +/-2.2%. For TMS, discrepancies between 
measured and calculated output for the oblique field are, therefore, just within the 
uncertainty range of the measurements, and are therefore insignificant.
Both systems overestimate outputs for the bolus experiment; after subtracting the
1.2 % systematic error from the calculated data, TMS overestimates by 2.7% and 
Cadplan by 1.9%. The result of the Cadplan calculation lies, therefore, within the 
expected range, while that of TMS falls just outside. The point at whieh output 
was measured and calculated in the bolus phantom was subject to a dose gradient, 
as an examination of figure 2.12 shows. Consequently, there will be some 
additional uncertainty in the measured output for this experiment due to the 
uncertainty in the TLD position. The diserepancy in the TMS ealculation, is 
therefore unlikely to be significant.
Samuelsson et al [20] report consistent underestimation of outputs by Cadplan for 
test geometries involving off-axis normalisation, as is the case in the bolus 
experiment. This is caused by the computer model’s failure to account for 
modifications to the beam fiuenee introdueed by the scattering foil. The TMS 
algorithm has the same omission. If present, this effect would partially offset the 
overestimation in calculated output caused by errors in the phantom scatter 
algorithms, and suggests therefore, that the errors in phantom scatter are larger than 
the figures quoted above.
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Appendix A5.1
Conversion from ionisation to absorbed dose with Roos 34001 chamber
For measurements made with the Roos chamber, the IPEMB 1996 Code of Practice 
[34] states that the absorbed dose to water, Dw, at a depth Z is:
Dw,z ~ M X No,air X Sw/air X Pch (1)
Where M is the corrected chamber reading in arbitrary units given on the 
electrometer display; No,air is a calibration factor relating the chamber reading to 
absorbed dose to air, and arises from the calibration of the Roos chamber against a 
secondary standard chamber; Sw,air is the (energy dependent) water to air stopping 
power ratio at depth Z, and Pch is the chamber perturbation factor.
The values of Swair and Pch are tabulated in the Code of Practice. S^ /air has a value 
of 1.039 for a 12 MeV beam, for example, while Pch has a value of 1.000 for the 
Roos chamber. The value of No,air was assessed when the Roos chamber was 
calibrated against the secondary standard in accordance with the Code of Practice.
Corrections to the chamber reading, M, were made for the effects of ion 
recombination; the chamber polarity; and the temperature and pressure. Ion 
reeombination can have a significant impact on collector efficiency; it’s effects 
were eorrected for by assessing the ratio of chamber readings at full to half voltage. 
The correction factor for the effects of temperature and pressure, fr,p is given in the 
Code of Practice as
fT,P = (273.15 + 7)(1013.25)/(293.15)P (2)
where T  and P are the temperature and pressure respectively.
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CHAPTER 6 
CONCLUSIONS
This work examined the accuracy of dose calculations performed by the Varian 
Cadplan and Helax TMS treatment planning systems. Calculated doses were 
compared with measurements made in electron beams produced by a Varian 
2100C linear accelerator.
The degree of accuracy required by a treatment planning system is that which is 
acceptable to the clinician responsible for the patient’s treatment. In practice, this 
will usually coincide with the criteria for accuracy laid down by the International 
Commission on Radiation Units and Measurements (ICRU). The ICRU have 
stipulated limits on the discrepancy with the actual dose value that a calculated 
dose may have. In this work, the “actual” value of dose was determined by 
measurement. Calculated doses, therefore, were proven to be inaccurate only if 
they fell outside the range of values defined by the uncertainty limits of the 
measurements.
In assessing the accuracy of dose calculation by a treatment planning system, it is 
important to specify the defect in the calculation algorithm which caused a given 
error. Only then can the information be used to assess the likely impact of this 
defect on a range of situations. For the two treatment planning systems under 
consideration, this is best achieved by considering the calculation of relative and 
absolute doses separately since quite distinct algorithms are employed in their 
calculation.
The calculation of relative dose was assessed in chapters two, three and four. 
Chapter two examined planar isodose distributions in three situations: oblique 
incidence of the electron beam; incidence on an irregular surface designed to 
resemble a region of bolus; and incidence on a phantom containing a small 
cylindrical air cavity. Chapter three considered the nature of the electron beam 
penumbra at extended FSD, and how this affects the optimum gap required 
between abutting electron and photon fields. Chapter four examined the shape of
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the region enclosed by the 90% isodose line in situations where beam-defining 
inserts are used.
In drawing conclusions on the suitability of the treatment planning systems for 
clinical use, it is reasonable to place greater emphasis on the results from chapter 
two. This is because the clinical situations simulated in this comparison require 
the use of a treatment planning system for dose calculation more often than those 
described in chapters three and four.
Of the three practical situations assessed in chapter two, those relating to oblique 
incidence and incidence on a surface containing a bolus edge were calculated with 
generally acceptable accuracy by both planning systems. Some exceptions were 
noted, however. TMS produced significant errors at the low dose margin of the 
distal penumbra for the oblique field. Both planning systems incorrectly estimated 
the hot spot dose caused by scattered electrons under the bolus edge. The general 
form of these dose distributions was, however, ealculated with sufficient aceuracy 
by both planning systems to justify their clinical use. The calculated dose 
distributions must, of course, be interpreted with caution. The planning computers 
should not be relied on in situations where the dose outside the nominal edge of an 
oblique field, or in the highest dose area underneath a bolus edge, require to be 
known precisely.
Reliance on the planning computers’ calculation would also be inadvisable if the 
electron beam under consideration passes through a patient or phantom containing 
a small air cavity. Both planning systems significantly underestimated (by 10%) 
the doses immediately downstream of a 1.5 cm diameter air cavity. The error was 
caused by the semi-infinite slab approximation used in modelling lateral electron 
scatter. For this reason, it is likely that a similar overestimation in dose will occur 
downstream of a small area of high density. Neither planning system, therefore, 
can be relied on to calculate accurately clinical dose distributions in the vicinity of 
small air cavities such as the trachea, nor small areas of raised density such as 
bones.
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The comparison of measured and calculated electron beam penumbra (considered 
in chapter three) demonstrated that the simplified model of electron scatter in air 
used by the planning systems provides insufficient accuracy at extended SSD. 
Whereas the position of the penumbra centre was predicted with acceptable 
accuracy, the penumbra width was not. Interpretation of computed penumbras 
thus requires caution, particularly at the low and high dose margins of the 
penumbra. Since these are often important clinically, computed isodose 
distributions should not be relied on at SSDs beyond 105 cm. If information on 
the dose coverage at extended SSD is required, it would be preferable to consult 
measured data. The same preeaution should be observed when positioning an 
extended SSD electron field with abutting photon fields. Optimum gap sizes 
(determined from measurements) between extended SSD electron fields and 
isocentric parallel opposed photon fields were tabulated in chapter three for this 
purpose.
Chapter four eonfirmed the suitability of the TMS system for displaying the 90% 
isodose line arising from the use of various field-shaping inserts. When a plane 
normal to the beam central axis is considered, the calculated 90% isodose line may 
thus be used as a template to indicate the extent and shape of the region receiving 
this dose. It has been proposed that the TMS system be used to produce 90% dose 
templates for the standard range of elliptical beam shaping inserts used in breast 
boost radiotherapy at the Beatson Oncology Centre. The results of chapters two 
and three demonstrate that these templates may only be applied to treatments at the 
standard SSD, and which do not involve a significantly oblique angle of incidence. 
The majority of electron boost treatments to the breast are likely to satisfy these 
conditions.
While chapters two, three and four revealed spécifié instances of inaccuracy in the 
calculation of relative dose by both planning systems, chapter five showed a great 
many errors in the caleulation of absolute dose. The comparison of measured and 
calculated monitor units demonstrated that the TMS system uses insufficient detail 
when modelling head scatter events to provide reliable results for electron fields 
with dimensions less than 5 x 5  cm. Cadplan’s reliance on measured data,
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however, gave better results.
In contrast, Cadplan’s use of measured data did not lead to the accurate calculation 
of monitor units for 10x10 cm fields at extended SSD. Significant errors arose 
due to an inability to reproduce values of virtual SSD stored in this system’s own 
data tables. This matter has been taken up with the manufacturer but has not been 
resolved at the time of writing. As with small fields, the calculation accuracy 
obtained by TMS at extended SSD suffered because head scatter events were not 
modelled explicitly. Only an implicit model characterised by a r.m.s. scattering 
angle optimised, not for the monitor unit calculation, but for reproduction of the 
field penumbra profile, was used. As a result, unacceptable errors in calculated 
monitor unit values arose for a variety of beam energies and sizes at SSDs above 
100 cm.
The comparison of measured and ealeulated absolute dose revealed serious 
deficiencies in the monitor unit calculation algorithms of both TMS and Cadplan. 
Their use for monitor unit caleulations for electron beams is, therefore, not 
recommended. Relative electron dose distributions from both planning systems 
may, on the other hand, be relied upon in a clinical setting provided care is taken in 
interpreting dose distributions. The physicist and clinician must be particularly 
aware of the potential errors in the calculation of electron beam penumbra, and 
dose distributions surrounding surface irregularities and small heterogeneities.
Future work
Algorithms for the calculation of absorbed dose from clinical electron beams are 
evolving continuously. The next step forward for commercially available 
treatment planning systems is likely to be the introduction of the phase space 
evolution algorithm. This involves a more complete description of the position, 
direction and energy (or phase) of electrons than that of the generalised Gaussian 
pencil beam. As with any new beam calculation algorithm, a rigorous comparison 
with measured data will be required before phase space evolution models of
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electron behaviour are introduced clinically. The experiments developed in this 
work to test the accuracy of pencil beam algorithms would be equally suitable in 
these future comparisons. Adopting these tests again would, moreover, allow the 
direct comparison of the phase space evolution and pencil beam algorithms.
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